| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | NCOA3 ASXL1 MAML1 ARID1A PHF2 KMT2C TSC22D1 ARID1B BRDT PARP9 NIPBL ZNF653 CNOT2 MED12 PARP15 MIER2 TCF20 MED8 NUP98 SETD4 MED1 HIPK3 YEATS2 PARP10 KMT2D TOX2 HCFC1 | 5.13e-12 | 562 | 191 | 27 | GO:0003712 |
| GeneOntologyMolecularFunction | transcription coactivator activity | NCOA3 ASXL1 MAML1 ARID1A PHF2 KMT2C TSC22D1 ARID1B BRDT MED12 TCF20 NUP98 SETD4 MED1 KMT2D TOX2 HCFC1 | 5.77e-09 | 303 | 191 | 17 | GO:0003713 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NCOA3 ASXL1 IRGM MAML1 ARID1A PHF2 KMT2C TSC22D1 ARID1B BRDT SLA2 PARP9 BAIAP2 NIPBL ZNF653 CNOT2 MED12 PARP15 MIER2 SH3RF1 TCF20 ANK1 MED8 NUP98 SETD4 MED1 HIPK3 YEATS2 PARP10 KMT2D RACGAP1 TOX2 HCFC1 | 1.66e-08 | 1160 | 191 | 33 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | UBL7 NCOA3 SP1 ASXL1 IRGM MAML1 ARID1A PHF2 KMT2C TSC22D1 ARID1B BRDT SLA2 PARP9 BAIAP2 NIPBL BAG6 ZNF653 CNOT2 MED12 PARP15 MIER2 SH3RF1 TCF20 ANK1 MED8 NUP98 SETD4 MED1 HIPK3 YEATS2 PARP10 KMT2D RACGAP1 TOX2 HCFC1 | 1.98e-08 | 1356 | 191 | 36 | GO:0060090 |
| GeneOntologyMolecularFunction | chromatin binding | NCOA3 ASXL1 ZNF609 SRF ZNF683 CHD3 ARID1A HNF4A ARID1B GLI3 NIPBL MED12 EP400 NUP98 POU2F1 CHD8 MLLT10 MED1 ASXL3 FOXP1 ASXL2 NFAT5 TOX2 HCFC1 | 1.75e-07 | 739 | 191 | 24 | GO:0003682 |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 9.85e-07 | 9 | 191 | 4 | GO:0015379 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 1.37e-06 | 21 | 191 | 5 | GO:0042975 | |
| GeneOntologyMolecularFunction | transcription factor binding | BDP1 NCOA3 SP1 ASXL1 SRF ARID1A HNF4A NFYA PARP9 BAIAP2 TAF4B ZNF653 CNOT2 MED12 MED1 YEATS2 PARP10 ARID2 FOXP1 NFAT5 TOX2 HCFC1 | 3.37e-06 | 753 | 191 | 22 | GO:0008134 |
| GeneOntologyMolecularFunction | ammonium channel activity | 3.78e-06 | 12 | 191 | 4 | GO:0008519 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 4.66e-05 | 8 | 191 | 3 | GO:0140945 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 6.23e-05 | 23 | 191 | 4 | GO:0015377 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 1.03e-04 | 26 | 191 | 4 | GO:0015296 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | DYRK4 NEK9 MAP3K4 ALPK3 WNK2 CDC42BPG CDKL2 HIPK3 PIKFYVE CSNK1G2 CSNK2A3 PLK4 | 2.04e-04 | 363 | 191 | 12 | GO:0106310 |
| GeneOntologyMolecularFunction | transcription corepressor activity | 3.72e-04 | 229 | 191 | 9 | GO:0003714 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | MYLK DYRK4 NEK9 MAP3K4 ALPK3 WNK2 CDC42BPG CDKL2 HIPK3 PIKFYVE CSNK1G2 CSNK2A3 PLK4 | 3.78e-04 | 446 | 191 | 13 | GO:0004674 |
| GeneOntologyMolecularFunction | transcription coregulator binding | 4.04e-04 | 140 | 191 | 7 | GO:0001221 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 4.19e-04 | 37 | 191 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | NCOA3 SP1 ASXL1 SRF ARID1A HNF4A PARP9 TAF4B ZNF653 MED12 MED1 PARP10 FOXP1 TOX2 HCFC1 | 4.98e-04 | 582 | 191 | 15 | GO:0140297 |
| GeneOntologyMolecularFunction | mediator complex binding | 5.39e-04 | 4 | 191 | 2 | GO:0036033 | |
| GeneOntologyMolecularFunction | symporter activity | 6.11e-04 | 150 | 191 | 7 | GO:0015293 | |
| GeneOntologyMolecularFunction | protein kinase activity | MYLK DYRK4 NEK9 MAP3K4 EFEMP1 ALPK3 WNK2 CDC42BPG CDKL2 HIPK3 PIKFYVE CSNK1G2 CSNK2A3 PLK4 EPHA7 | 6.81e-04 | 600 | 191 | 15 | GO:0004672 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | NCOA3 SP1 ASXL1 SRF ARID1A HNF4A PARP9 TAF4B MED12 MED1 FOXP1 TOX2 | 7.08e-04 | 417 | 191 | 12 | GO:0061629 |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 8.71e-04 | 20 | 191 | 3 | GO:0042800 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 1.21e-03 | 83 | 191 | 5 | GO:1990841 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | MYLK DYRK4 NEK9 MAP3K4 EFEMP1 ALPK3 PARP9 WNK2 PARP15 CDC42BPG CDKL2 HIPK3 PIKFYVE PARP10 CSNK1G2 GYS2 CSNK2A3 PLK4 EPHA7 | 1.69e-03 | 938 | 191 | 19 | GO:0016772 |
| GeneOntologyMolecularFunction | protein domain specific binding | NCOA3 IRGM ADAM15 HNF4A SYNGAP1 KIDINS220 UBR5 PKD1 BAIAP2 ADGRL2 NIPBL ZNF653 CHMP1B CHD8 MED1 SLC34A1 SLC22A4 SRRM2 | 1.89e-03 | 875 | 191 | 18 | GO:0019904 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NCOA3 SP1 ASXL1 ZNF609 MAML1 SRF HNF4A CASZ1 ZNF462 KMT2C TSC22D1 GLI3 PKD1 NFYA PLAG1 TAF4B NIPBL MED12 NOTCH3 TFEC LHX4 TCF20 MED8 POU2F1 SETD4 CHD8 MLLT10 MED1 RFX7 KMT2D ASXL3 ARID2 GMEB1 FOXP1 ASXL2 NFAT5 TOX2 HCFC1 | 1.36e-09 | 1390 | 191 | 38 | GO:0045944 |
| GeneOntologyBiologicalProcess | embryo development | NCOA3 SP1 USP9X SRF CLASP2 ARID1A HNF4A KIDINS220 GLI3 PKD1 STRA6 NIPBL BAG6 CNOT2 MED12 VCAM1 CCDC40 TBX15 POU2F1 CHD8 TNRC6C STIL MED1 EPN2 WDR74 YEATS2 KMT2D TENM4 ARID2 RACGAP1 FOXP1 ANKRD24 ASXL2 ZNF281 PLK4 HCFC1 CRB2 | 1.16e-08 | 1437 | 191 | 37 | GO:0009790 |
| GeneOntologyBiologicalProcess | embryonic organ development | NCOA3 SP1 SRF ARID1A GLI3 PKD1 STRA6 NIPBL MED12 VCAM1 CCDC40 TBX15 TNRC6C STIL MED1 EPN2 ARID2 ANKRD24 ASXL2 PLK4 CRB2 | 6.24e-08 | 561 | 191 | 21 | GO:0048568 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | BDP1 NCOA3 ASXL1 CHD3 ARID1A ZNF462 PHF2 KMT2C ARID1B BRDT UBR5 TAF4B NIPBL BAG6 MIER2 CENPT EP400 MED8 SETD4 CHD8 MED1 YEATS2 PARP10 KMT2D ARID2 NFAT5 HCFC1 | 5.71e-07 | 999 | 191 | 27 | GO:0071824 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | NCOA3 SP1 ASXL1 MYLK ADAM15 SRF ARID1A CASZ1 ALMS1 SGPL1 GLI3 PKD1 NGFR PLAG1 STRA6 NIPBL MED12 CCDC40 TBX15 COL10A1 LHX4 MUC19 POU2F1 STIL MED1 SLC34A1 ASXL3 ARID2 ANKRD24 ASXL2 CRB2 | 6.74e-07 | 1269 | 191 | 31 | GO:0009887 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | NCOA3 SP1 SRF CLASP2 ARID1A HNF4A GLI3 STRA6 NIPBL MED12 VCAM1 CCDC40 TBX15 POU2F1 TNRC6C STIL MED1 TENM4 ANKRD24 ASXL2 ZNF281 CRB2 | 8.17e-07 | 713 | 191 | 22 | GO:0048598 |
| GeneOntologyBiologicalProcess | ammonium import across plasma membrane | 3.11e-06 | 4 | 191 | 3 | GO:0140157 | |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 3.89e-06 | 99 | 191 | 8 | GO:0045995 | |
| GeneOntologyBiologicalProcess | ammonium transmembrane transport | 4.77e-06 | 13 | 191 | 4 | GO:0072488 | |
| GeneOntologyBiologicalProcess | growth | NCOA3 USP9X ADAM15 SRF CLASP2 ARHGEF11 HNF4A SLC12A5 KMT2C ALMS1 SGPL1 GLI3 PLAG1 STRA6 NIPBL MED12 FOXK1 ALOX15B PUM2 STIL MED1 LEPR KMT2D TENM4 ARID2 FOXP1 CSNK2A3 EPHA7 | 1.02e-05 | 1235 | 191 | 28 | GO:0040007 |
| GeneOntologyBiologicalProcess | chordate embryonic development | NCOA3 SP1 USP9X SRF ARID1A KIDINS220 GLI3 PKD1 NIPBL CNOT2 MED12 VCAM1 TBX15 CHD8 STIL MED1 EPN2 WDR74 KMT2D ASXL2 PLK4 HCFC1 CRB2 | 1.17e-05 | 906 | 191 | 23 | GO:0043009 |
| GeneOntologyBiologicalProcess | developmental growth | NCOA3 USP9X ADAM15 SRF CLASP2 SLC12A5 KMT2C ALMS1 SGPL1 GLI3 PLAG1 STRA6 NIPBL MED12 PUM2 STIL MED1 LEPR KMT2D TENM4 ARID2 FOXP1 EPHA7 | 1.28e-05 | 911 | 191 | 23 | GO:0048589 |
| GeneOntologyBiologicalProcess | positive regulation of response to type II interferon | 1.53e-05 | 6 | 191 | 3 | GO:0060332 | |
| GeneOntologyBiologicalProcess | positive regulation of type II interferon-mediated signaling pathway | 1.53e-05 | 6 | 191 | 3 | GO:0060335 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | NCOA3 SP1 USP9X SRF ARID1A KIDINS220 GLI3 PKD1 NIPBL CNOT2 MED12 VCAM1 TBX15 CHD8 STIL MED1 EPN2 WDR74 KMT2D ASXL2 PLK4 HCFC1 CRB2 | 1.75e-05 | 929 | 191 | 23 | GO:0009792 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | NCOA3 ASXL1 ARID1A UBR5 CNOT2 ALOX15B MED1 KMT2D FOXP1 ASXL2 | 1.96e-05 | 202 | 191 | 10 | GO:0141193 |
| GeneOntologyBiologicalProcess | circulatory system development | SP1 ASXL1 MYLK ADAM15 MAML1 SRF ARID1A ITGB3 SGPL1 GLI3 PKD1 ALPK3 NGFR FGF12 STRA6 NIPBL MED12 VCAM1 NOTCH3 CCDC40 SLC12A6 STIL MED1 LEPR EPN2 TENM4 ARID2 FOXP1 ASXL2 CRB2 | 2.49e-05 | 1442 | 191 | 30 | GO:0072359 |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | SP1 SRF ARID1A GLI3 STRA6 NIPBL MED12 CCDC40 TBX15 STIL ANKRD24 ASXL2 CRB2 | 2.52e-05 | 351 | 191 | 13 | GO:0048562 |
| GeneOntologyBiologicalProcess | heart development | ASXL1 ADAM15 MAML1 SRF ARID1A GLI3 PKD1 ALPK3 FGF12 STRA6 NIPBL MED12 VCAM1 CCDC40 STIL MED1 TENM4 ARID2 FOXP1 ASXL2 | 2.58e-05 | 757 | 191 | 20 | GO:0007507 |
| GeneOntologyBiologicalProcess | chromatin organization | NCOA3 ASXL1 CHD3 ARID1A ZNF462 PHF2 KMT2C ARID1B BRDT UBR5 NIPBL BAG6 MIER2 EP400 SETD4 CHD8 YEATS2 PARP10 KMT2D ARID2 NFAT5 HCFC1 | 3.06e-05 | 896 | 191 | 22 | GO:0006325 |
| GeneOntologyBiologicalProcess | regulation of gastrulation | 3.07e-05 | 20 | 191 | 4 | GO:0010470 | |
| GeneOntologyBiologicalProcess | tube development | NCOA3 SP1 ASXL1 MYLK ADAM15 SRF ARID1A ITGB3 SGPL1 GLI3 PKD1 NGFR STRA6 NIPBL BAG6 MED12 NOTCH3 CCDC40 SLC12A6 MUC19 CHD8 TNRC6C STIL MED1 LEPR EPN2 ARID2 FOXP1 EPHA7 | 3.84e-05 | 1402 | 191 | 29 | GO:0035295 |
| GeneOntologyBiologicalProcess | in utero embryonic development | NCOA3 SP1 USP9X SRF KIDINS220 GLI3 PKD1 CNOT2 VCAM1 CHD8 STIL MED1 EPN2 WDR74 KMT2D PLK4 HCFC1 | 4.19e-05 | 596 | 191 | 17 | GO:0001701 |
| GeneOntologyBiologicalProcess | chloride ion homeostasis | 7.74e-05 | 25 | 191 | 4 | GO:0055064 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | USP9X SRF CHD3 ARID1A HNF4A GLI3 SLA2 PARP9 NIPBL ZNF653 CNOT2 FOXK1 NOTCH3 PARP15 TBX15 MIER2 TFEC POU2F1 CHD8 DEPDC1 MED1 HIPK3 YEATS2 PARP10 FOXP1 ASXL2 ZNF281 HCFC1 | 9.37e-05 | 1399 | 191 | 28 | GO:0045892 |
| GeneOntologyBiologicalProcess | placenta development | 9.52e-05 | 197 | 191 | 9 | GO:0001890 | |
| GeneOntologyBiologicalProcess | potassium ion import across plasma membrane | 1.07e-04 | 51 | 191 | 5 | GO:1990573 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | USP9X SRF CHD3 ARID1A HNF4A GLI3 SLA2 PARP9 NIPBL ZNF653 CNOT2 FOXK1 NOTCH3 PARP15 TBX15 MIER2 TFEC POU2F1 CHD8 DEPDC1 MED1 HIPK3 YEATS2 PARP10 FOXP1 ASXL2 ZNF281 HCFC1 | 1.11e-04 | 1413 | 191 | 28 | GO:1902679 |
| GeneOntologyBiologicalProcess | chromosome segregation | ANKRD31 USP9X CLASP2 ARID1A ARID1B NCAPD2 NIPBL BAG6 CENPT CHMP1B PUM2 STIL ARID2 RACGAP1 | 1.16e-04 | 465 | 191 | 14 | GO:0007059 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | USP9X CHD3 ARID1A GLI3 SLA2 PARP9 NIPBL ZNF653 CNOT2 FOXK1 NOTCH3 PARP15 TBX15 MIER2 TFEC CHD8 MED1 HIPK3 YEATS2 FOXP1 ASXL2 ZNF281 HCFC1 | 1.19e-04 | 1053 | 191 | 23 | GO:0000122 |
| GeneOntologyBiologicalProcess | tube morphogenesis | NCOA3 SP1 MYLK ADAM15 SRF ARID1A ITGB3 SGPL1 GLI3 PKD1 NGFR STRA6 NIPBL MED12 NOTCH3 CCDC40 SLC12A6 STIL MED1 LEPR EPN2 ARID2 FOXP1 EPHA7 | 1.20e-04 | 1125 | 191 | 24 | GO:0035239 |
| GeneOntologyBiologicalProcess | protein poly-ADP-ribosylation | 1.22e-04 | 11 | 191 | 3 | GO:0070212 | |
| GeneOntologyBiologicalProcess | peroxisome proliferator activated receptor signaling pathway | 1.23e-04 | 28 | 191 | 4 | GO:0035357 | |
| GeneOntologyBiologicalProcess | monoatomic anion homeostasis | 1.23e-04 | 28 | 191 | 4 | GO:0055081 | |
| GeneOntologyBiologicalProcess | eye morphogenesis | 1.24e-04 | 204 | 191 | 9 | GO:0048592 | |
| GeneOntologyBiologicalProcess | respiratory system development | SP1 ASXL1 SRF GLI3 STRA6 BAG6 CCDC40 MUC19 POU2F1 TNRC6C FOXP1 | 1.35e-04 | 305 | 191 | 11 | GO:0060541 |
| GeneOntologyBiologicalProcess | smooth muscle tissue development | 1.41e-04 | 29 | 191 | 4 | GO:0048745 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | NCOA3 ASXL1 IRGM ARID1A HNF4A UBR5 CNOT2 ALOX15B PUM2 MED1 KMT2D FOXP1 ASXL2 | 1.41e-04 | 416 | 191 | 13 | GO:0030522 |
| GeneOntologyBiologicalProcess | positive regulation of intracellular estrogen receptor signaling pathway | 1.62e-04 | 12 | 191 | 3 | GO:0033148 | |
| GeneOntologyBiologicalProcess | hemopoiesis | SP1 ASXL1 IRGM ZNF609 SRF ZNF683 ARID1A ITGB3 TSC22D1 ARID1B SGPL1 GLI3 VCAM1 PTBP3 SMAP1 SH3RF1 ANK1 MUC19 TNRC6C MED1 LEPR ARID2 RACGAP1 FOXP1 ASXL2 | 1.67e-04 | 1223 | 191 | 25 | GO:0030097 |
| GeneOntologyBiologicalProcess | estrogen receptor signaling pathway | 1.83e-04 | 57 | 191 | 5 | GO:0030520 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | NCOA3 CHD3 ARID1A PHF2 KMT2C ARID1B BRDT UBR5 NIPBL MIER2 EP400 SETD4 CHD8 YEATS2 KMT2D ARID2 NFAT5 HCFC1 | 1.90e-04 | 741 | 191 | 18 | GO:0006338 |
| GeneOntologyBiologicalProcess | kidney development | ASXL1 AMER1 ITGB3 SGPL1 GLI3 PKD1 STRA6 NIPBL BAG6 NOTCH3 SLC34A1 EPHA7 | 1.91e-04 | 372 | 191 | 12 | GO:0001822 |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 1.98e-04 | 171 | 191 | 8 | GO:0048593 | |
| GeneOntologyBiologicalProcess | skeletal system development | SP1 ASXL1 AMER1 SRF EFEMP1 SGPL1 GLI3 PKD1 NIPBL MED12 TBX15 COL10A1 PUM2 LEPR FOXP1 ASXL2 | 2.04e-04 | 615 | 191 | 16 | GO:0001501 |
| GeneOntologyBiologicalProcess | intracellular glucose homeostasis | 2.04e-04 | 218 | 191 | 9 | GO:0001678 | |
| GeneOntologyBiologicalProcess | lung saccule development | 2.09e-04 | 13 | 191 | 3 | GO:0060430 | |
| GeneOntologyBiologicalProcess | lung development | 2.14e-04 | 269 | 191 | 10 | GO:0030324 | |
| GeneOntologyBiologicalProcess | positive regulation of epidermis development | 2.36e-04 | 33 | 191 | 4 | GO:0045684 | |
| GeneOntologyBiologicalProcess | respiratory tube development | 2.40e-04 | 273 | 191 | 10 | GO:0030323 | |
| GeneOntologyBiologicalProcess | T cell differentiation | IRGM ZNF609 SRF ZNF683 ARID1A ARID1B GLI3 SH3RF1 MUC19 LEPR ARID2 FOXP1 | 2.43e-04 | 382 | 191 | 12 | GO:0030217 |
| GeneOntologyBiologicalProcess | artery development | 2.44e-04 | 133 | 191 | 7 | GO:0060840 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle | ANKRD31 TSC22D2 ARID1A HNF4A NEK9 ARID1B ALMS1 PKD1 NCAPD2 PARP9 FOXK1 ALOX15B EP400 CDKL2 CHMP1B PUM2 STIL MED1 YEATS2 ARID2 RACGAP1 CDC25A CSNK2A3 PLK4 HCFC1 | 2.50e-04 | 1256 | 191 | 25 | GO:0051726 |
| GeneOntologyBiologicalProcess | nose morphogenesis | 2.54e-04 | 3 | 191 | 2 | GO:0043585 | |
| GeneOntologyBiologicalProcess | hypotonic response | 2.64e-04 | 14 | 191 | 3 | GO:0006971 | |
| GeneOntologyBiologicalProcess | renal system development | ASXL1 AMER1 ITGB3 SGPL1 GLI3 PKD1 STRA6 NIPBL BAG6 NOTCH3 SLC34A1 EPHA7 | 2.67e-04 | 386 | 191 | 12 | GO:0072001 |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 2.79e-04 | 136 | 191 | 7 | GO:0030518 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | ARHGEF11 SLC12A5 WNK2 SLC12A6 SLC12A4 SLC34A1 SLC22A4 SLC24A1 SLC12A7 | 3.04e-04 | 230 | 191 | 9 | GO:0098739 |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 3.14e-04 | 231 | 191 | 9 | GO:0006352 | |
| GeneOntologyBiologicalProcess | body morphogenesis | 3.16e-04 | 64 | 191 | 5 | GO:0010171 | |
| GeneOntologyBiologicalProcess | regulation of response to type II interferon | 3.28e-04 | 15 | 191 | 3 | GO:0060330 | |
| GeneOntologyBiologicalProcess | regulation of type II interferon-mediated signaling pathway | 3.28e-04 | 15 | 191 | 3 | GO:0060334 | |
| GeneOntologyBiologicalProcess | regulation of intracellular estrogen receptor signaling pathway | 3.33e-04 | 36 | 191 | 4 | GO:0033146 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 3.50e-04 | 186 | 191 | 8 | GO:0006367 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 3.63e-04 | 142 | 191 | 7 | GO:0098659 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 3.63e-04 | 142 | 191 | 7 | GO:0099587 | |
| GeneOntologyBiologicalProcess | potassium ion homeostasis | 3.71e-04 | 37 | 191 | 4 | GO:0055075 | |
| GeneOntologyBiologicalProcess | eyelid development in camera-type eye | 4.01e-04 | 16 | 191 | 3 | GO:0061029 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription initiation by RNA polymerase II | 4.80e-04 | 70 | 191 | 5 | GO:0060261 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | IRGM ZNF609 ZNF683 ARID1A ITGB3 TSC22D1 ARID1B GLI3 SMAP1 SH3RF1 MED1 ARID2 FOXP1 ASXL2 | 5.28e-04 | 540 | 191 | 14 | GO:1903706 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | SP1 ADAM15 SRF CLASP2 ARID1A ITGB3 GLI3 PKD1 AGFG1 NGFR STRA6 CNOT2 MED12 NOTCH3 SLC12A6 POU2F1 TNRC6C STIL MED1 LEPR PRX EPN2 PIKFYVE WDR74 TENM4 SLC34A1 CRB2 | 5.69e-04 | 1483 | 191 | 27 | GO:0048646 |
| GeneOntologyBiologicalProcess | nose development | 5.76e-04 | 18 | 191 | 3 | GO:0043584 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular steroid hormone receptor signaling pathway | 5.76e-04 | 18 | 191 | 3 | GO:0033145 | |
| GeneOntologyBiologicalProcess | regulation of peroxisome proliferator activated receptor signaling pathway | 5.76e-04 | 18 | 191 | 3 | GO:0035358 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 6.06e-04 | 42 | 191 | 4 | GO:0070316 | |
| GeneOntologyBiologicalProcess | cell volume homeostasis | 6.06e-04 | 42 | 191 | 4 | GO:0006884 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 6.14e-04 | 155 | 191 | 7 | GO:0043401 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | NCOA3 MYLK SRF CLASP2 ARID1A ITGB3 ALMS1 GLI3 PKD1 NGFR MED12 CCDC40 STIL MED1 FOXP1 CRB2 EPHA7 | 6.32e-04 | 750 | 191 | 17 | GO:0048729 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | NCOA3 SRF CLASP2 ARID1A ITGB3 ALMS1 GLI3 PKD1 NGFR MED12 CCDC40 STIL MED1 FOXP1 EPHA7 | 6.74e-04 | 619 | 191 | 15 | GO:0002009 |
| GeneOntologyBiologicalProcess | positive regulation of keratinocyte differentiation | 6.79e-04 | 19 | 191 | 3 | GO:0045618 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 7.24e-04 | 44 | 191 | 4 | GO:0045023 | |
| GeneOntologyBiologicalProcess | gland development | NCOA3 SP1 ASXL1 ATP7B SRF PHF2 GLI3 PKD1 PLAG1 STRA6 ALOX15B CCDC40 MUC19 MED1 | 7.28e-04 | 558 | 191 | 14 | GO:0048732 |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription initiation | 7.44e-04 | 77 | 191 | 5 | GO:2000144 | |
| GeneOntologyBiologicalProcess | embryonic placenta development | 8.51e-04 | 119 | 191 | 6 | GO:0001892 | |
| GeneOntologyBiologicalProcess | regulation of transcription initiation by RNA polymerase II | 9.37e-04 | 81 | 191 | 5 | GO:0060260 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | IRGM ZNF609 SRF ZNF683 ARID1A ARID1B GLI3 VCAM1 SH3RF1 MUC19 MED1 LEPR ARID2 FOXP1 ASXL2 | 9.44e-04 | 640 | 191 | 15 | GO:1903131 |
| GeneOntologyBiologicalProcess | import into cell | ZFYVE16 ARHGEF11 ITGB3 SLC12A5 ALMS1 STRA6 WNK2 SLC12A6 SMAP1 SIGLEC14 LEPR EPN2 PIKFYVE USP6 SLC12A4 SLC34A1 CSNK1G2 SLC22A4 CLINT1 SLC24A1 SLC12A7 | 1.01e-03 | 1074 | 191 | 21 | GO:0098657 |
| GeneOntologyBiologicalProcess | regulation of cell size | 1.22e-03 | 225 | 191 | 8 | GO:0008361 | |
| GeneOntologyBiologicalProcess | mammary gland branching involved in thelarche | 1.25e-03 | 6 | 191 | 2 | GO:0060744 | |
| GeneOntologyBiologicalProcess | uterus morphogenesis | 1.25e-03 | 6 | 191 | 2 | GO:0061038 | |
| GeneOntologyBiologicalProcess | thelarche | 1.25e-03 | 6 | 191 | 2 | GO:0042695 | |
| GeneOntologyBiologicalProcess | response to ionomycin | 1.25e-03 | 6 | 191 | 2 | GO:1904636 | |
| GeneOntologyBiologicalProcess | cellular response to ionomycin | 1.25e-03 | 6 | 191 | 2 | GO:1904637 | |
| GeneOntologyBiologicalProcess | negative regulation of hematopoietic stem cell proliferation | 1.25e-03 | 6 | 191 | 2 | GO:1902034 | |
| GeneOntologyBiologicalProcess | glucose homeostasis | 1.26e-03 | 338 | 191 | 10 | GO:0042593 | |
| GeneOntologyBiologicalProcess | regulation of cell development | IRGM ZNF609 SRF ZNF683 ARID1A ITGB3 CASZ1 SYNGAP1 TSC22D1 ARID1B GLI3 PLAG1 BAIAP2 SMAP1 SH3RF1 MED1 TENM4 ARID2 FOXP1 ASXL2 EPHA7 | 1.28e-03 | 1095 | 191 | 21 | GO:0060284 |
| GeneOntologyBiologicalProcess | carbohydrate homeostasis | 1.28e-03 | 339 | 191 | 10 | GO:0033500 | |
| GeneOntologyBiologicalProcess | regulation of intracellular steroid hormone receptor signaling pathway | 1.29e-03 | 87 | 191 | 5 | GO:0033143 | |
| GeneOntologyBiologicalProcess | erythrocyte differentiation | 1.29e-03 | 176 | 191 | 7 | GO:0030218 | |
| GeneOntologyBiologicalProcess | regulation of centrosome duplication | 1.36e-03 | 52 | 191 | 4 | GO:0010824 | |
| GeneOntologyCellularComponent | PR-DUB complex | 2.89e-06 | 4 | 189 | 3 | GO:0035517 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NCOA3 ASXL1 CHD3 ARID1A KMT2C ARID1B NUP210 NFYA AGFG1 TAF4B NIPBL MED12 TBX15 EP400 CHMP1B MED8 NUP98 POU2F1 CHD8 MED1 INTS8 IVNS1ABP WDR74 KMT2D ASXL3 ARID2 INTS4 ASXL2 SRRM2 HCFC1 | 6.44e-06 | 1377 | 189 | 30 | GO:0140513 |
| GeneOntologyCellularComponent | chromatin | ANKRD31 NCOA3 SP1 SRF CHD3 ARID1A HNF4A CASZ1 ARID1B BRDT UBR5 NFYA NIPBL FOXK1 TBX15 TFEC LHX4 EP400 ADNP2 POU2F1 CHD8 MED1 RFX7 YEATS2 ARID2 GMEB1 FOXP1 NFAT5 HCFC1 | 6.56e-05 | 1480 | 189 | 29 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | BDP1 NCOA3 SP1 CHD3 GLI3 NFYA TAF4B TBX15 MED8 POU2F1 DEPDC1 MED1 IVNS1ABP ARID2 NFAT5 | 3.55e-04 | 596 | 189 | 15 | GO:0005667 |
| HumanPheno | Delayed speech and language development | ASXL1 AMER1 USP9X CHD3 ARID1A CASZ1 SYNGAP1 ZNF462 KMT2C ARID1B KIDINS220 ALMS1 GLI3 NCAPD2 PLAG1 FGF12 NIPBL CNOT2 MED12 CCDC40 SLC12A6 TCF20 CHD8 STIL RFX7 INTS8 KMT2D ASXL3 ARID2 FOXP1 ASXL2 ZBTB11 SRRM2 PLK4 | 5.40e-06 | 1123 | 75 | 34 | HP:0000750 |
| HumanPheno | Language impairment | ASXL1 AMER1 USP9X CHD3 ARID1A CASZ1 SYNGAP1 ZNF462 KMT2C ARID1B KIDINS220 ALMS1 GLI3 NCAPD2 PLAG1 FGF12 NIPBL CNOT2 MED12 NOTCH3 CCDC40 SLC12A6 TCF20 CHD8 STIL RFX7 INTS8 KMT2D ASXL3 ARID2 FOXP1 ASXL2 ZBTB11 SRRM2 PLK4 | 5.49e-06 | 1178 | 75 | 35 | HP:0002463 |
| HumanPheno | Abnormal eating behavior | ARID1A CASZ1 SYNGAP1 ARID1B ALMS1 CHD8 RFX7 LEPR ARID2 SRRM2 | 1.46e-05 | 128 | 75 | 10 | HP:0100738 |
| HumanPheno | Posteriorly rotated ears | ASXL1 AMER1 USP9X CASZ1 ARID1B GLI3 GTF2IRD2 NIPBL MED12 NOTCH3 TBX15 TCF20 CHD8 RFX7 KMT2D ASXL3 ARID2 ASXL2 SRRM2 | 3.22e-05 | 470 | 75 | 19 | HP:0000358 |
| HumanPheno | Aggressive behavior | ATP7B USP9X VPS13C ARID1A SUCLG1 CASZ1 SYNGAP1 KMT2C ARID1B FGF12 NIPBL MED12 TCF20 CHD8 STIL RFX7 LEPR ASXL3 ARID2 FOXP1 | 3.49e-05 | 516 | 75 | 20 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | ATP7B USP9X VPS13C ARID1A SUCLG1 CASZ1 SYNGAP1 KMT2C ARID1B FGF12 NIPBL MED12 TCF20 CHD8 STIL RFX7 LEPR ASXL3 ARID2 FOXP1 | 3.49e-05 | 516 | 75 | 20 | HP:0006919 |
| HumanPheno | Broad philtrum | 4.30e-05 | 45 | 75 | 6 | HP:0000289 | |
| HumanPheno | Hirsutism | ASXL1 ARID1A CASZ1 ARID1B ALMS1 GLI3 NIPBL CNOT2 TBX15 KMT2D ASXL3 ARID2 | 6.10e-05 | 216 | 75 | 12 | HP:0001007 |
| HumanPheno | Autistic behavior | USP9X CHD3 ARID1A CASZ1 SYNGAP1 ZNF462 KMT2C ARID1B ALMS1 NCAPD2 GTF2IRD2 FGF12 NIPBL MED12 TCF20 CHD8 RFX7 KMT2D ASXL3 ARID2 SBF2 FOXP1 SRRM2 | 6.52e-05 | 678 | 75 | 23 | HP:0000729 |
| HumanPheno | Prominent eyelashes | 8.92e-05 | 17 | 75 | 4 | HP:0011231 | |
| HumanPheno | Compulsive behaviors | USP9X SYNGAP1 ARID1B GTF2IRD2 NIPBL MED12 TCF20 RFX7 ARID2 FOXP1 | 9.05e-05 | 158 | 75 | 10 | HP:0000722 |
| HumanPheno | Thin upper lip vermilion | USP9X ARID1A SYNGAP1 ARID1B NIPBL CNOT2 MED12 TCF20 STIL RFX7 KMT2D ASXL3 ARID2 ASXL2 SRRM2 | 9.46e-05 | 339 | 75 | 15 | HP:0000219 |
| HumanPheno | Thin lips | USP9X ARID1A SYNGAP1 ARID1B NIPBL CNOT2 MED12 TCF20 STIL RFX7 KMT2D ASXL3 ARID2 ASXL2 SRRM2 | 9.46e-05 | 339 | 75 | 15 | HP:0000213 |
| HumanPheno | Patent ductus arteriosus | AMER1 MYLK USP9X ARID1A SUCLG1 CASZ1 ARID1B GLI3 GTF2IRD2 STRA6 MED12 NOTCH3 ANK1 KMT2D ARID2 ASXL2 | 1.02e-04 | 382 | 75 | 16 | HP:0001643 |
| HumanPheno | Hypoplastic fingernail | 1.10e-04 | 53 | 75 | 6 | HP:0001804 | |
| HumanPheno | Disinhibition | ATP7B USP9X VPS13C CHD3 ARID1A SUCLG1 CASZ1 SYNGAP1 KMT2C ARID1B GLI3 GTF2IRD2 PLAG1 FGF12 NIPBL MED12 TCF20 CHD8 STIL RFX7 LEPR ASXL3 ARID2 FOXP1 SRRM2 | 1.27e-04 | 807 | 75 | 25 | HP:0000734 |
| HumanPheno | Inappropriate behavior | ATP7B USP9X VPS13C CHD3 ARID1A SUCLG1 CASZ1 SYNGAP1 KMT2C ARID1B GLI3 GTF2IRD2 PLAG1 FGF12 NIPBL MED12 TCF20 CHD8 STIL RFX7 LEPR ASXL3 ARID2 FOXP1 SRRM2 | 1.27e-04 | 807 | 75 | 25 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | ATP7B USP9X VPS13C CHD3 ARID1A SUCLG1 CASZ1 SYNGAP1 KMT2C ARID1B GLI3 GTF2IRD2 PLAG1 FGF12 NIPBL MED12 TCF20 CHD8 STIL RFX7 LEPR ASXL3 ARID2 FOXP1 SRRM2 | 1.27e-04 | 807 | 75 | 25 | HP:5200123 |
| HumanPheno | Social disinhibition | ATP7B USP9X VPS13C CHD3 ARID1A SUCLG1 CASZ1 SYNGAP1 KMT2C ARID1B GLI3 GTF2IRD2 PLAG1 FGF12 NIPBL MED12 TCF20 CHD8 STIL RFX7 LEPR ASXL3 ARID2 FOXP1 SRRM2 | 1.27e-04 | 807 | 75 | 25 | HP:5200029 |
| HumanPheno | Abnormal pinna morphology | ASXL1 AMER1 USP9X CHD3 ARID1A NEK9 CASZ1 SYNGAP1 ZNF462 KMT2C ARID1B EFEMP1 ALMS1 GLI3 GTF2IRD2 PLAG1 STRA6 NIPBL CNOT2 MED12 NOTCH3 TBX15 SLC12A6 TCF20 ANK1 CHD8 RFX7 KMT2D ASXL3 ARID2 FOXP1 ASXL2 SRRM2 PLK4 | 1.40e-04 | 1299 | 75 | 34 | HP:0000377 |
| HumanPheno | Inguinal hernia | MYLK CHD3 ARID1A KMT2C ARID1B EFEMP1 GLI3 GTF2IRD2 PLAG1 STRA6 NIPBL MED12 NOTCH3 KMT2D | 1.45e-04 | 312 | 75 | 14 | HP:0000023 |
| HumanPheno | Thick lower lip vermilion | AMER1 ARID1A SYNGAP1 KMT2C ARID1B GTF2IRD2 MED12 KMT2D ARID2 | 1.49e-04 | 136 | 75 | 9 | HP:0000179 |
| HumanPheno | Expressive language delay | 1.51e-04 | 56 | 75 | 6 | HP:0002474 | |
| HumanPheno | Language delay | 1.51e-04 | 56 | 75 | 6 | HP:0002336 | |
| HumanPheno | Narrow palate | ASXL1 AMER1 MYLK NEK9 EFEMP1 NIPBL MED12 NOTCH3 KMT2D ASXL3 ARID2 | 1.53e-04 | 202 | 75 | 11 | HP:0000189 |
| HumanPheno | Abnormally increased volition | ATP7B USP9X VPS13C CHD3 ARID1A SUCLG1 HNF4A CASZ1 SYNGAP1 KMT2C ARID1B GLI3 GTF2IRD2 PLAG1 FGF12 NIPBL MED12 TCF20 CHD8 STIL RFX7 LEPR ASXL3 ARID2 FOXP1 SRRM2 | 1.58e-04 | 869 | 75 | 26 | HP:5200263 |
| HumanPheno | Narrow face | 1.63e-04 | 108 | 75 | 8 | HP:0000275 | |
| HumanPheno | Intellectual disability, moderate | USP9X ARID1A SYNGAP1 ARID1B NCAPD2 MED12 ASXL3 ARID2 FOXP1 ZBTB11 | 1.84e-04 | 172 | 75 | 10 | HP:0002342 |
| HumanPheno | Abnormality of the palpebral fissures | ASXL1 USP9X NEK9 SYNGAP1 ZNF462 KMT2C ARID1B EFEMP1 GLI3 GTF2IRD2 FGF12 STRA6 CNOT2 MED12 NOTCH3 TBX15 CENPT ANK1 CHD8 STIL RFX7 KMT2D ASXL3 ARID2 FOXP1 PLK4 | 1.95e-04 | 880 | 75 | 26 | HP:0008050 |
| HumanPheno | Abnormality of the forehead | ASXL1 AMER1 USP9X CHD3 ARID1A CASZ1 SYNGAP1 ZNF462 ARID1B EFEMP1 KIDINS220 GLI3 NCAPD2 GTF2IRD2 PLAG1 FGF12 NIPBL MED12 NOTCH3 TBX15 SLC12A6 LHX4 TCF20 STIL RFX7 INTS8 KMT2D ASXL3 ARID2 FOXP1 ASXL2 PLK4 | 2.03e-04 | 1208 | 75 | 32 | HP:0000290 |
| HumanPheno | Thick nasal alae | 2.36e-04 | 39 | 75 | 5 | HP:0009928 | |
| HumanPheno | Abnormality of the outer ear | ASXL1 AMER1 USP9X CHD3 ARID1A NEK9 CASZ1 SYNGAP1 ZNF462 KMT2C ARID1B EFEMP1 ALMS1 GLI3 GTF2IRD2 PLAG1 STRA6 NIPBL CNOT2 MED12 NOTCH3 TBX15 SLC12A6 TCF20 ANK1 CHD8 RFX7 KMT2D ASXL3 ARID2 FOXP1 ASXL2 SRRM2 PLK4 | 2.55e-04 | 1337 | 75 | 34 | HP:0000356 |
| HumanPheno | Brachycephaly | AMER1 USP9X CASZ1 KMT2C ARID1B KIDINS220 NIPBL MED12 SLC12A6 TCF20 RFX7 HCFC1 | 2.76e-04 | 253 | 75 | 12 | HP:0000248 |
| HumanPheno | Hernia of the abdominal wall | AMER1 MYLK CHD3 ARID1A NEK9 KMT2C ARID1B EFEMP1 GLI3 GTF2IRD2 PLAG1 STRA6 NIPBL MED12 NOTCH3 LHX4 RFX7 KMT2D | 2.85e-04 | 506 | 75 | 18 | HP:0004299 |
| HumanPheno | Diagnostic behavioral phenotype | USP9X CHD3 ARID1A CASZ1 SYNGAP1 ZNF462 KMT2C ARID1B ALMS1 NCAPD2 GTF2IRD2 FGF12 NIPBL MED12 TCF20 CHD8 RFX7 KMT2D ASXL3 ARID2 SBF2 FOXP1 SRRM2 | 2.91e-04 | 747 | 75 | 23 | HP:0025783 |
| HumanPheno | Abnormality of upper lip vermillion | USP9X ARID1A SYNGAP1 ZNF462 ARID1B NIPBL CNOT2 MED12 TCF20 CHD8 STIL RFX7 KMT2D ASXL3 ARID2 ASXL2 SRRM2 | 3.08e-04 | 464 | 75 | 17 | HP:0011339 |
| HumanPheno | Perseverative thought | USP9X CHD3 CASZ1 SYNGAP1 ARID1B GTF2IRD2 NIPBL MED12 NOTCH3 TCF20 CHD8 RFX7 ASXL3 ARID2 FOXP1 | 3.09e-04 | 377 | 75 | 15 | HP:0030223 |
| HumanPheno | Short 5th finger | 3.17e-04 | 64 | 75 | 6 | HP:0009237 | |
| HumanPheno | Abdominal wall defect | AMER1 MYLK CHD3 ARID1A NEK9 KMT2C ARID1B EFEMP1 GLI3 GTF2IRD2 PLAG1 STRA6 NIPBL MED12 NOTCH3 LHX4 RFX7 KMT2D | 3.22e-04 | 511 | 75 | 18 | HP:0010866 |
| HumanPheno | Thoracoabdominal wall defect | AMER1 MYLK CHD3 ARID1A NEK9 KMT2C ARID1B EFEMP1 GLI3 GTF2IRD2 PLAG1 STRA6 NIPBL MED12 NOTCH3 LHX4 RFX7 KMT2D | 3.22e-04 | 511 | 75 | 18 | HP:0100656 |
| HumanPheno | Abnormality of the abdominal wall | AMER1 MYLK USP9X CHD3 ARID1A NEK9 KMT2C ARID1B EFEMP1 GLI3 GTF2IRD2 PLAG1 STRA6 NIPBL MED12 NOTCH3 LHX4 RFX7 KMT2D | 3.43e-04 | 560 | 75 | 19 | HP:0004298 |
| HumanPheno | Prominent forehead | ASXL1 AMER1 USP9X CHD3 SYNGAP1 KIDINS220 PLAG1 MED12 LHX4 KMT2D ASXL3 FOXP1 | 3.68e-04 | 261 | 75 | 12 | HP:0011220 |
| HumanPheno | Aplasia/Hypoplasia of the 5th finger | 3.76e-04 | 66 | 75 | 6 | HP:0006262 | |
| HumanPheno | Ectopic kidney | 3.89e-04 | 93 | 75 | 7 | HP:0000086 | |
| HumanPheno | Disordered formal thought process | USP9X CHD3 CASZ1 SYNGAP1 ARID1B GTF2IRD2 NIPBL MED12 NOTCH3 TCF20 CHD8 RFX7 ASXL3 ARID2 FOXP1 | 3.99e-04 | 386 | 75 | 15 | HP:0025769 |
| HumanPheno | Abnormal ventricular septum morphology | ASXL1 AMER1 CHD3 ARID1A NEK9 ZNF462 ARID1B GLI3 ALPK3 GTF2IRD2 STRA6 NIPBL MED12 NOTCH3 RFX7 KMT2D ARID2 CRB2 | 4.09e-04 | 521 | 75 | 18 | HP:0010438 |
| HumanPheno | Prominent lips | AMER1 ARID1A SYNGAP1 KMT2C ARID1B GTF2IRD2 MED12 KMT2D ARID2 | 4.19e-04 | 156 | 75 | 9 | HP:0000184 |
| HumanPheno | Reduced impulse control | ASXL1 ATP7B USP9X VPS13C CHD3 ARID1A SUCLG1 HNF4A CASZ1 SYNGAP1 KMT2C ARID1B ALMS1 GLI3 GTF2IRD2 PLAG1 FGF12 NIPBL MED12 TCF20 CHD8 STIL RFX7 LEPR ASXL3 ARID2 FOXP1 SRRM2 | 4.36e-04 | 1032 | 75 | 28 | HP:5200045 |
| HumanPheno | Intestinal malrotation | 4.39e-04 | 157 | 75 | 9 | HP:0002566 | |
| HumanPheno | Abnormal upper lip morphology | ASXL1 AMER1 USP9X ARID1A NEK9 CASZ1 SYNGAP1 ZNF462 ARID1B EFEMP1 KIDINS220 GLI3 GTF2IRD2 NIPBL CNOT2 MED12 NOTCH3 LHX4 TCF20 CHD8 STIL RFX7 KMT2D ASXL3 ARID2 ASXL2 SRRM2 | 4.54e-04 | 980 | 75 | 27 | HP:0000177 |
| HumanPheno | Congenital malformation of the great arteries | AMER1 MYLK USP9X ARID1A SUCLG1 CASZ1 ZNF462 ARID1B GLI3 GTF2IRD2 STRA6 MED12 NOTCH3 CCDC40 ANK1 KMT2D ARID2 ASXL2 | 4.93e-04 | 529 | 75 | 18 | HP:0011603 |
| HumanPheno | Accelerated skeletal maturation | 5.17e-04 | 70 | 75 | 6 | HP:0005616 | |
| HumanPheno | Toe deformity | 5.52e-04 | 129 | 75 | 8 | HP:0034398 | |
| HumanPheno | Increased body weight | ATP7B HNF4A CASZ1 KMT2C KIDINS220 ALMS1 GLI3 GTF2IRD2 NIPBL COL10A1 LHX4 TCF20 CHD8 LEPR KMT2D FOXP1 SRRM2 | 6.00e-04 | 491 | 75 | 17 | HP:0004324 |
| HumanPheno | Overlapping toe | 6.02e-04 | 72 | 75 | 6 | HP:0001845 | |
| HumanPheno | Recurrent upper respiratory tract infections | USP9X ARID1A ARID1B ALMS1 GLI3 CCDC40 RFX7 LEPR IVNS1ABP ARID2 FOXP1 | 6.11e-04 | 237 | 75 | 11 | HP:0002788 |
| HumanPheno | Severe expressive language delay | 6.13e-04 | 12 | 75 | 3 | HP:0006863 | |
| HumanPheno | Abnormal location of ears | ASXL1 AMER1 USP9X CHD3 NEK9 CASZ1 SYNGAP1 ZNF462 ARID1B GLI3 GTF2IRD2 PLAG1 STRA6 NIPBL CNOT2 MED12 NOTCH3 TBX15 TCF20 CHD8 RFX7 KMT2D ASXL3 ARID2 ASXL2 SRRM2 | 6.25e-04 | 945 | 75 | 26 | HP:0000357 |
| HumanPheno | Abnormal cardiac septum morphology | ASXL1 AMER1 USP9X CHD3 ARID1A SUCLG1 NEK9 CASZ1 ZNF462 ARID1B GLI3 ALPK3 GTF2IRD2 STRA6 NIPBL MED12 NOTCH3 ANK1 RFX7 KMT2D ARID2 ASXL2 CRB2 | 6.28e-04 | 787 | 75 | 23 | HP:0001671 |
| HumanPheno | Abnormal morphology of the great vessels | AMER1 MYLK USP9X ARID1A SUCLG1 NEK9 CASZ1 SLC12A5 ZNF462 ARID1B GLI3 PKD1 GTF2IRD2 STRA6 MED12 NOTCH3 CCDC40 ANK1 STIL KMT2D ARID2 ASXL2 | 6.30e-04 | 736 | 75 | 22 | HP:0030962 |
| HumanPheno | Abnormal toe morphology | ASXL1 AMER1 MYLK USP9X ARID1A NEK9 CASZ1 ARID1B EFEMP1 ALMS1 GLI3 GTF2IRD2 NIPBL CNOT2 MED12 TBX15 SLC12A6 TCF20 RFX7 INTS8 PRX KMT2D ASXL3 SBF2 PLK4 | 6.42e-04 | 893 | 75 | 25 | HP:0001780 |
| HumanPheno | Abnormal thought pattern | USP9X CHD3 CASZ1 SYNGAP1 ARID1B GTF2IRD2 NIPBL MED12 NOTCH3 TCF20 CHD8 RFX7 ASXL3 ARID2 FOXP1 | 6.48e-04 | 404 | 75 | 15 | HP:5200269 |
| HumanPheno | Hernia | AMER1 MYLK CHD3 ARID1A NEK9 KMT2C ARID1B EFEMP1 GLI3 GTF2IRD2 PLAG1 STRA6 NIPBL MED12 NOTCH3 LHX4 RFX7 KMT2D ARID2 | 6.51e-04 | 589 | 75 | 19 | HP:0100790 |
| HumanPheno | Ventriculomegaly | ASXL1 USP9X CHD3 ARID1A CASZ1 ZNF462 KMT2C ARID1B KIDINS220 GLI3 ALPK3 NIPBL MED12 CCDC40 SLC12A6 STIL PRX KMT2D ASXL3 ARID2 ASXL2 ZBTB11 CRB2 | 6.63e-04 | 790 | 75 | 23 | HP:0002119 |
| HumanPheno | Slanting of the palpebral fissure | ASXL1 USP9X NEK9 SYNGAP1 ZNF462 ARID1B EFEMP1 GLI3 FGF12 CNOT2 MED12 NOTCH3 CENPT ANK1 CHD8 STIL RFX7 KMT2D ASXL3 ARID2 FOXP1 PLK4 | 6.67e-04 | 739 | 75 | 22 | HP:0200006 |
| HumanPheno | Wide nasal base | 6.79e-04 | 28 | 75 | 4 | HP:0012810 | |
| HumanPheno | Abnormal sacrum morphology | 6.90e-04 | 167 | 75 | 9 | HP:0005107 | |
| HumanPheno | Downslanted palpebral fissures | USP9X NEK9 SYNGAP1 ZNF462 ARID1B EFEMP1 GLI3 FGF12 MED12 NOTCH3 CENPT CHD8 KMT2D ASXL3 ARID2 FOXP1 PLK4 | 6.90e-04 | 497 | 75 | 17 | HP:0000494 |
| HumanPheno | Short stature | ASXL1 AMER1 USP9X ARID1A HNF4A CASZ1 SYNGAP1 KMT2C ARID1B ALMS1 GLI3 NCAPD2 GTF2IRD2 PLAG1 FGF12 STRA6 NIPBL MED12 NOTCH3 TBX15 COL10A1 CENPT LHX4 ANK1 STIL INTS8 LEPR KMT2D SLC34A1 ARID2 GYS2 RACGAP1 PLK4 HCFC1 | 7.13e-04 | 1407 | 75 | 34 | HP:0004322 |
| HumanPheno | Abnormal eyelid morphology | ASXL1 AMER1 USP9X CHD3 ARID1A NEK9 CASZ1 SYNGAP1 ZNF462 KMT2C ARID1B EFEMP1 GLI3 GTF2IRD2 FGF12 STRA6 NIPBL CNOT2 MED12 NOTCH3 TBX15 CENPT TCF20 ANK1 CHD8 STIL RFX7 KMT2D ASXL3 ARID2 FOXP1 ASXL2 SRRM2 PLK4 | 7.23e-04 | 1408 | 75 | 34 | HP:0000492 |
| HumanPheno | Agenesis of corpus callosum | ASXL1 AMER1 ARID1A CASZ1 ZNF462 ARID1B KIDINS220 GLI3 MED12 SLC12A6 LHX4 STIL ARID2 PLK4 | 7.31e-04 | 365 | 75 | 14 | HP:0001274 |
| HumanPheno | Short nose | ARID1A ZNF462 ARID1B GLI3 GTF2IRD2 NIPBL SLC12A6 TCF20 RFX7 KMT2D ASXL3 ARID2 FOXP1 | 7.84e-04 | 325 | 75 | 13 | HP:0003196 |
| HumanPheno | Restricted or repetitive behaviors or interests | USP9X CHD3 CASZ1 SYNGAP1 ARID1B GTF2IRD2 NIPBL MED12 TCF20 CHD8 RFX7 ASXL3 ARID2 FOXP1 | 7.93e-04 | 368 | 75 | 14 | HP:0031432 |
| HumanPheno | Abnormal social development | ATP7B USP9X VPS13C CHD3 ARID1A SUCLG1 CASZ1 SYNGAP1 KMT2C ARID1B GLI3 GTF2IRD2 PLAG1 FGF12 NIPBL MED12 TCF20 CHD8 STIL RFX7 LEPR ASXL3 ARID2 FOXP1 SRRM2 | 8.28e-04 | 908 | 75 | 25 | HP:0025732 |
| HumanPheno | Wide nasal bridge | ASXL1 AMER1 USP9X CHD3 CASZ1 SYNGAP1 ARID1B GLI3 GTF2IRD2 STRA6 MED12 SLC12A6 CHD8 RFX7 KMT2D ASXL3 PLK4 | 8.87e-04 | 508 | 75 | 17 | HP:0000431 |
| HumanPheno | Abnormal nasal base norphology | 8.89e-04 | 30 | 75 | 4 | HP:0012808 | |
| HumanPheno | Polyphagia | 9.24e-04 | 78 | 75 | 6 | HP:0002591 | |
| HumanPheno | Abnormal nasopharynx morphology | USP9X ARID1A ARID1B ALMS1 GLI3 CCDC40 RFX7 LEPR IVNS1ABP ARID2 FOXP1 | 9.24e-04 | 249 | 75 | 11 | HP:0001739 |
| HumanPheno | Ventricular septal defect | ASXL1 AMER1 CHD3 ARID1A NEK9 ZNF462 ARID1B GLI3 GTF2IRD2 STRA6 NIPBL MED12 NOTCH3 RFX7 KMT2D ARID2 CRB2 | 9.27e-04 | 510 | 75 | 17 | HP:0001629 |
| HumanPheno | Hypoplastic fifth fingernail | 9.93e-04 | 14 | 75 | 3 | HP:0008398 | |
| HumanPheno | Small face | 1.04e-03 | 142 | 75 | 8 | HP:0000274 | |
| HumanPheno | Sacral dimple | 1.07e-03 | 110 | 75 | 7 | HP:0000960 | |
| HumanPheno | Gastroesophageal reflux | ASXL1 AMER1 USP9X SUCLG1 CASZ1 SYNGAP1 KMT2C ALMS1 GTF2IRD2 FGF12 NIPBL MED12 CENPT STIL KMT2D ASXL3 ARID2 | 1.08e-03 | 517 | 75 | 17 | HP:0002020 |
| HumanPheno | Dislocated radial head | 1.09e-03 | 54 | 75 | 5 | HP:0003083 | |
| HumanPheno | Aplastic/hypoplastic fingernail | 1.20e-03 | 82 | 75 | 6 | HP:0008384 | |
| MousePheno | abnormal myocardium compact layer morphology | 1.30e-05 | 67 | 164 | 7 | MP:0004056 | |
| Domain | KCL_cotranspt | 1.04e-08 | 4 | 190 | 4 | IPR000076 | |
| Domain | SLC12A_fam | 3.55e-07 | 7 | 190 | 4 | IPR004842 | |
| Domain | ZF_PHD_2 | 5.34e-07 | 95 | 190 | 9 | PS50016 | |
| Domain | ZF_PHD_1 | 5.84e-07 | 96 | 190 | 9 | PS01359 | |
| Domain | SLC12_C | 7.04e-07 | 8 | 190 | 4 | IPR018491 | |
| Domain | SLC12 | 7.04e-07 | 8 | 190 | 4 | PF03522 | |
| Domain | HARE-HTH | 1.04e-06 | 3 | 190 | 3 | PF05066 | |
| Domain | ASXH | 1.04e-06 | 3 | 190 | 3 | PF13919 | |
| Domain | PHD_3 | 1.04e-06 | 3 | 190 | 3 | PF13922 | |
| Domain | ASX-like_PHD | 1.04e-06 | 3 | 190 | 3 | IPR026905 | |
| Domain | ASXH | 1.04e-06 | 3 | 190 | 3 | IPR028020 | |
| Domain | ASX/ASX-like | 1.04e-06 | 3 | 190 | 3 | IPR024811 | |
| Domain | HB1/Asxl_HTH | 1.04e-06 | 3 | 190 | 3 | IPR007759 | |
| Domain | Znf_PHD | 3.97e-05 | 91 | 190 | 7 | IPR001965 | |
| Domain | AA-permease/SLC12A_dom | 6.58e-05 | 22 | 190 | 4 | IPR004841 | |
| Domain | EPHD | 6.58e-05 | 22 | 190 | 4 | PS51805 | |
| Domain | AA_permease | 6.58e-05 | 22 | 190 | 4 | PF00324 | |
| Domain | - | USP9X CLASP2 ARID1A ARID1B NCAPD2 PUM3 NIPBL MED12 PUM2 INTS4 | 9.50e-05 | 222 | 190 | 10 | 1.25.10.10 |
| Domain | BAF250/Osa | 1.03e-04 | 2 | 190 | 2 | IPR021906 | |
| Domain | BAF250_C | 1.03e-04 | 2 | 190 | 2 | IPR033388 | |
| Domain | KCC1 | 1.03e-04 | 2 | 190 | 2 | IPR000622 | |
| Domain | Cohesin_HEAT | 1.03e-04 | 2 | 190 | 2 | PF12765 | |
| Domain | BAF250_C | 1.03e-04 | 2 | 190 | 2 | PF12031 | |
| Domain | Cohesin_HEAT | 1.03e-04 | 2 | 190 | 2 | IPR026003 | |
| Domain | ARM-like | USP9X CLASP2 ARID1A ARID1B NCAPD2 PUM3 NIPBL MED12 PUM2 ARID2 INTS4 | 1.04e-04 | 270 | 190 | 11 | IPR011989 |
| Domain | Znf_FYVE_PHD | 1.32e-04 | 147 | 190 | 8 | IPR011011 | |
| Domain | PHD | 2.96e-04 | 89 | 190 | 6 | SM00249 | |
| Domain | PUM_HD | 3.07e-04 | 3 | 190 | 2 | PS50303 | |
| Domain | SPAR_C | 3.07e-04 | 3 | 190 | 2 | PF11881 | |
| Domain | PUM-HD | 3.07e-04 | 3 | 190 | 2 | IPR033133 | |
| Domain | SIPA1L_C | 3.07e-04 | 3 | 190 | 2 | IPR021818 | |
| Domain | - | 4.31e-04 | 15 | 190 | 3 | 1.10.150.60 | |
| Domain | BRIGHT | 4.31e-04 | 15 | 190 | 3 | SM00501 | |
| Domain | ARID_dom | 4.31e-04 | 15 | 190 | 3 | IPR001606 | |
| Domain | ARID | 4.31e-04 | 15 | 190 | 3 | PS51011 | |
| Domain | ARID | 4.31e-04 | 15 | 190 | 3 | PF01388 | |
| Domain | - | 6.09e-04 | 4 | 190 | 2 | 3.90.1460.10 | |
| Domain | TSC-22_Dip_Bun | 6.09e-04 | 4 | 190 | 2 | IPR000580 | |
| Domain | TSC-22_Dip_Bun | 6.09e-04 | 4 | 190 | 2 | PD007152 | |
| Domain | PUM | 6.09e-04 | 4 | 190 | 2 | PS50302 | |
| Domain | Pumilio_RNA-bd_rpt | 6.09e-04 | 4 | 190 | 2 | IPR001313 | |
| Domain | GTF2I | 6.09e-04 | 4 | 190 | 2 | PS51139 | |
| Domain | GTF2I | 6.09e-04 | 4 | 190 | 2 | PF02946 | |
| Domain | TSC22 | 6.09e-04 | 4 | 190 | 2 | PF01166 | |
| Domain | GTF2I | 6.09e-04 | 4 | 190 | 2 | IPR004212 | |
| Domain | Pumilio | 6.09e-04 | 4 | 190 | 2 | SM00025 | |
| Domain | TSC22 | 6.09e-04 | 4 | 190 | 2 | PS01289 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 6.34e-04 | 17 | 190 | 3 | IPR012317 | |
| Domain | PARP_CATALYTIC | 6.34e-04 | 17 | 190 | 3 | PS51059 | |
| Domain | PARP | 6.34e-04 | 17 | 190 | 3 | PF00644 | |
| Domain | - | 6.34e-04 | 17 | 190 | 3 | 3.90.228.10 | |
| Domain | PHD | 1.00e-03 | 75 | 190 | 5 | PF00628 | |
| Domain | FYrich_C | 1.01e-03 | 5 | 190 | 2 | IPR003889 | |
| Domain | FYrich_N | 1.01e-03 | 5 | 190 | 2 | IPR003888 | |
| Domain | FYRC | 1.01e-03 | 5 | 190 | 2 | SM00542 | |
| Domain | FYRN | 1.01e-03 | 5 | 190 | 2 | SM00541 | |
| Domain | FYRN | 1.01e-03 | 5 | 190 | 2 | PF05964 | |
| Domain | FYRC | 1.01e-03 | 5 | 190 | 2 | PF05965 | |
| Domain | FYRC | 1.01e-03 | 5 | 190 | 2 | PS51543 | |
| Domain | FYRN | 1.01e-03 | 5 | 190 | 2 | PS51542 | |
| Domain | S_TKc | MYLK DYRK4 NEK9 MAP3K4 WNK2 CDC42BPG CDKL2 HIPK3 CSNK1G2 CSNK2A3 PLK4 | 1.16e-03 | 359 | 190 | 11 | SM00220 |
| Domain | PROTEIN_KINASE_ST | MYLK DYRK4 NEK9 MAP3K4 WNK2 CDC42BPG CDKL2 HIPK3 CSNK1G2 CSNK2A3 PLK4 | 1.24e-03 | 362 | 190 | 11 | PS00108 |
| Domain | Znf_PHD-finger | 1.27e-03 | 79 | 190 | 5 | IPR019787 | |
| Domain | ENTH | 1.50e-03 | 6 | 190 | 2 | PF01417 | |
| Domain | WGR_domain | 1.79e-03 | 24 | 190 | 3 | IPR008893 | |
| Domain | Pkinase | MYLK DYRK4 NEK9 MAP3K4 WNK2 CDC42BPG CDKL2 HIPK3 CSNK1G2 CSNK2A3 PLK4 | 1.86e-03 | 381 | 190 | 11 | PF00069 |
| Domain | ARM-type_fold | USP9X CLASP2 ARID1A FMNL2 NCAPD2 PUM3 NIPBL PUM2 ARID2 INTS4 | 2.54e-03 | 339 | 190 | 10 | IPR016024 |
| Domain | PROTEIN_KINASE_ATP | MYLK DYRK4 NEK9 MAP3K4 WNK2 CDC42BPG CDKL2 HIPK3 CSNK1G2 CSNK2A3 PLK4 EPHA7 | 2.66e-03 | 459 | 190 | 12 | PS00107 |
| Domain | PTB | 2.77e-03 | 8 | 190 | 2 | IPR013625 | |
| Domain | HEMATOPO_REC_L_F2 | 2.77e-03 | 8 | 190 | 2 | PS01353 | |
| Domain | PTB | 2.77e-03 | 8 | 190 | 2 | PF08416 | |
| Domain | HEAT | 2.87e-03 | 58 | 190 | 4 | IPR000357 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 3.57e-07 | 7 | 144 | 4 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 3.57e-07 | 7 | 144 | 4 | MM15081 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119 | 5.74e-06 | 26 | 144 | 5 | M47923 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.18e-04 | 108 | 144 | 7 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.25e-04 | 109 | 144 | 7 | MM15074 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 2.03e-04 | 29 | 144 | 4 | M48076 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA3 ZNF609 MAML1 ARID1A ZNF462 KMT2C ARID1B ALMS1 NIPBL MED12 FOXK1 TCF20 EP400 NUP98 POU2F1 CHD8 RFX7 KMT2D ASXL3 ARID2 FOXP1 ASXL2 ZNF281 ZMYM4 | 3.54e-19 | 351 | 194 | 24 | 38297188 |
| Pubmed | NCOA3 SP1 ASXL1 ZNF609 USP9X MAML1 CHD3 ARID1A HNF4A ZNF462 PHF2 KMT2C ARID1B ALMS1 GLI3 NFYA PUM3 NIPBL CNOT2 FOXK1 LHX4 TCF20 EP400 MED8 NUP98 PUM2 POU2F1 CHD8 TNRC6C MLLT10 RFX7 YEATS2 KMT2D ARID2 GMEB1 RACGAP1 FOXP1 ASXL2 SRRM2 ZNF281 HCFC1 ZMYM4 | 5.67e-19 | 1429 | 194 | 42 | 35140242 | |
| Pubmed | NCOA3 ZNF609 MAML1 CHD3 ARID1A CASZ1 ARID1B NIPBL MED12 FOXK1 TCF20 EP400 MED8 CHD8 MED1 KMT2D INTS4 FOXP1 ZNF281 HCFC1 | 6.87e-17 | 268 | 194 | 20 | 33640491 | |
| Pubmed | NCOA3 ZNF609 MAML1 CHD3 ARID1A PHF2 KMT2C ARID1B UBR5 PUM3 NIPBL BAG6 MED12 FOXK1 TCF20 EP400 MED8 POU2F1 CHD8 MED1 WDR74 YEATS2 KMT2D ARID2 GMEB1 FOXP1 ASXL2 CLINT1 SRRM2 ZNF281 HCFC1 ZMYM4 | 2.13e-14 | 1103 | 194 | 32 | 34189442 | |
| Pubmed | NCOA3 CHD3 ARID1A ARID1B NIPBL FOXK1 TCF20 EP400 POU2F1 MED1 KMT2D ZNF281 | 4.41e-14 | 83 | 194 | 12 | 28794006 | |
| Pubmed | BACE1 FMNL2 NEK9 CASZ1 ZNF462 PHF2 TSC22D1 ALMS1 SGPL1 NUP210 PUM3 MED12 MIER2 SH3RF1 PRX EPN2 PIKFYVE ARID2 SBF2 DIP2C ANKRD24 FHDC1 | 7.92e-14 | 493 | 194 | 22 | 15368895 | |
| Pubmed | ASXL1 ZFYVE16 MAP3K4 SLC12A5 KIDINS220 UBR5 ZFR2 NAV1 SIPA1L2 TCF20 EP400 PUM2 TNRC6C YEATS2 TENM4 SIPA1L1 ASXL2 SRRM2 NFAT5 SPATA13 | 1.93e-13 | 407 | 194 | 20 | 12693553 | |
| Pubmed | NCOA3 SP1 ZNF609 SRF CHD3 ARID1A ZNF462 PHF2 TSC22D1 BRDT GLI3 NFYA PLAG1 ZNF653 CNOT2 FOXK1 TBX15 MIER2 TCF20 POU2F1 MLLT10 PKHD1L1 ARID2 GMEB1 FOXP1 NFAT5 | 7.31e-13 | 808 | 194 | 26 | 20412781 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | CHD3 ARID1A ARID1B NUP210 NCAPD2 CNOT2 MED12 FOXK1 TCF20 EP400 CHD8 MED1 INTS8 UNC50 KMT2D SRRM2 ZNF281 HCFC1 | 9.87e-13 | 341 | 194 | 18 | 32971831 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 ZNF609 AMER1 VPS13C SRF CLASP2 CHD3 ARID1A NEK9 CASZ1 ZNF462 PHF2 KMT2C TSC22D1 KIDINS220 NUP210 NAV1 BAIAP2 WNK2 NOTCH3 SLC12A6 CDC42BPG TNRC6C INTS8 HIPK3 YEATS2 PARP10 RALGPS1 SBF2 DIP2C FOXP1 ANKRD24 NFAT5 ZMYM4 | 2.59e-12 | 1489 | 194 | 34 | 28611215 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MAML1 CLASP2 ARID1A ARHGEF11 CASZ1 KMT2C PKD1 NCAPD2 NAV1 SIPA1L2 MED12 FOXK1 WNK2 SH3RF1 EP400 CHD8 TNRC6C MLLT10 PIKFYVE KMT2D SLC12A4 SLC25A39 CSNK1G2 RALGPS1 SBF2 DIP2C HCFC1 SPATA13 CD276 | 4.68e-12 | 1105 | 194 | 29 | 35748872 |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | NCOA3 USP9X ARID1A ZNF462 KMT2C MED12 EP400 MED8 MED1 YEATS2 KMT2D HCFC1 ZMYM4 | 1.25e-11 | 167 | 194 | 13 | 20362541 |
| Pubmed | SP1 ARHGEF11 FMNL2 MAP3K4 KMT2C TSC22D1 NFYA AGFG1 NAV1 BAIAP2 WNK2 SH3RF1 TCF20 NUP98 ADNP2 CHD8 HIPK3 ARID2 ANKRD24 | 4.17e-11 | 486 | 194 | 19 | 20936779 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | NCOA3 SP1 SRF TSC22D2 HNF4A TSC22D1 GLI3 NFYA PLAG1 ZNF653 FOXK1 TBX15 TFEC CENPT LHX4 ADNP2 POU2F1 RFX7 YEATS2 KMT2D GMEB1 FOXP1 NFAT5 TOX2 ZNF281 | 5.86e-11 | 908 | 194 | 25 | 19274049 |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NCOA3 ZNF609 MAML1 ARID1A SUCLG1 KMT2C ARID1B NUP210 PUM3 STRA6 CNOT2 FOXK1 TCF20 NUP98 PUM2 YEATS2 KMT2D RAVER2 | 1.23e-10 | 457 | 194 | 18 | 32344865 |
| Pubmed | ZNF609 ATP7B ZFYVE16 ADAM15 VPS13C MAML1 CLASP2 RTN1 ARID1B ALMS1 SGPL1 AGFG1 NAV1 BAIAP2 CNOT2 TCF20 EP400 PUM2 PIKFYVE YEATS2 RACGAP1 HCFC1 | 1.81e-10 | 733 | 194 | 22 | 34672954 | |
| Pubmed | NCOA3 ZNF609 ZFYVE16 CHD3 NEK9 ZNF462 ALMS1 UBR5 NAV1 MED12 TCF20 CHD8 YEATS2 KMT2D FOXP1 ZBTB11 ZMYM4 | 2.53e-10 | 418 | 194 | 17 | 34709266 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | CHD3 CASZ1 ZNF462 PHF2 PUM3 NIPBL FOXK1 MIER2 CENPT TCF20 ADNP2 POU2F1 CHD8 MED1 ARID2 RACGAP1 ZBTB11 ZNF281 HCFC1 ZMYM4 | 2.63e-10 | 608 | 194 | 20 | 36089195 |
| Pubmed | USP9X ARID1A NEK9 KMT2C ARID1B ALMS1 NCAPD2 MED12 TCF20 EP400 MED8 CHD8 MED1 YEATS2 KMT2D ARID2 CLINT1 HCFC1 ZMYM4 | 3.25e-10 | 549 | 194 | 19 | 38280479 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | NCOA3 ZNF609 ARID1A CASZ1 ZNF462 KMT2C ARID1B MED12 TCF20 KMT2D ARID2 HCFC1 ZMYM4 | 3.90e-10 | 220 | 194 | 13 | 35785414 |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | ASXL1 USP9X DYRK4 ALMS1 NAV1 FGF12 BAIAP2 SIPA1L2 BAG6 CNOT2 MED12 FOXK1 EP400 CDKL2 MED8 MED1 HIPK3 FRY SIPA1L1 SRRM2 ZNF281 | 4.27e-10 | 695 | 194 | 21 | 23602568 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | AMER1 CLASP2 DYRK4 NEK9 ALMS1 AGFG1 NAV1 FAM83G BAIAP2 SIPA1L2 FOXK1 SH3RF1 TCF20 STIL RFX7 EPN2 IVNS1ABP SIPA1L1 RACGAP1 CLINT1 SRRM2 PLK4 SPATA13 | 6.50e-10 | 861 | 194 | 23 | 36931259 |
| Pubmed | NCOA3 SP1 NEK9 CASZ1 KMT2C ALMS1 GLI3 ZNF653 WNK2 TCF20 PIKFYVE PARP10 SRRM2 | 7.89e-10 | 233 | 194 | 13 | 37704626 | |
| Pubmed | ZNF609 ATP7B CHD3 ARID1A SUCLG1 FMNL2 PHF2 ARID1B ALMS1 BRDT UBR5 SGPL1 GLI3 TAF4B SIPA1L2 ADGRL2 FOXK1 EP400 ADNP2 CHD8 YEATS2 ARID2 SIPA1L1 FOXP1 SRRM2 ZNF281 | 8.39e-10 | 1116 | 194 | 26 | 31753913 | |
| Pubmed | 9.39e-10 | 4 | 194 | 4 | 12637262 | ||
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 1.01e-09 | 20 | 194 | 6 | 29785026 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NCOA3 ZNF609 MAML1 SRF ARID1A CASZ1 KMT2C ARID1B FOXK1 TCF20 EP400 ADNP2 YEATS2 KMT2D ARID2 FOXP1 | 1.03e-09 | 398 | 194 | 16 | 35016035 |
| Pubmed | ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer. | 1.26e-09 | 10 | 194 | 5 | 32669118 | |
| Pubmed | EPS8 MAML1 CLASP2 ARHGEF11 CASZ1 PHF2 KMT2C KIDINS220 SGPL1 NCAPD2 WDR89 PUM3 BAIAP2 NIPBL CNOT2 MED12 FOXK1 EP400 MED8 PUM2 CHD8 MED1 INTS8 EPN2 CSNK1G2 ARID2 SIPA1L1 ZBTB11 ZNF281 ZMYM4 | 1.30e-09 | 1497 | 194 | 30 | 31527615 | |
| Pubmed | NCOA3 CHD3 ARID1A ZNF462 KMT2C ALMS1 NUP210 NCAPD2 BAG6 EP400 NUP98 CHD8 KMT2D INTS4 ZNF281 HCFC1 ZMYM4 | 1.45e-09 | 469 | 194 | 17 | 27634302 | |
| Pubmed | ASXL1 ZNF462 PHF2 KMT2C ALMS1 UBR5 PUM2 CHD8 TNRC6C TENM4 SIPA1L1 DIP2C | 5.97e-09 | 225 | 194 | 12 | 12168954 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | SP1 CHD3 PUM3 BAIAP2 METTL17 NIPBL MED12 EP400 CHD8 WDR74 KMT2D SIPA1L1 RACGAP1 HCFC1 ZMYM4 | 1.23e-08 | 410 | 194 | 15 | 26949251 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZNF609 CHD3 ARID1A PHF2 ARID1B AGFG1 PUM3 NIPBL CENPT TCF20 EP400 NUP98 CHD8 MED1 YEATS2 ARID2 RACGAP1 CLINT1 SRRM2 ZNF281 HCFC1 ZMYM4 | 2.22e-08 | 954 | 194 | 22 | 36373674 |
| Pubmed | NCOA3 SP1 USP9X MAML1 ARID1A CASZ1 ARID1B NIPBL TCF20 MED8 MUC16 MED1 YEATS2 USP6 KMT2D ASXL3 ARID2 ZNF281 | 2.30e-08 | 638 | 194 | 18 | 31182584 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SP1 ZNF609 TSC22D2 ITGB3 NEK9 SYNGAP1 AGFG1 SLA2 WNK2 EP400 NUP98 MLLT10 PRX ARID2 CLINT1 | 2.30e-08 | 430 | 194 | 15 | 35044719 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | BDP1 USP9X CLASP2 ARHGEF11 MAP3K4 SYNGAP1 KMT2C NCAPD2 METTL17 BAG6 MED12 ANK1 WDR74 ARID2 CSNK2A3 HCFC1 | 2.36e-08 | 497 | 194 | 16 | 36774506 |
| Pubmed | SP1 ZNF609 USP9X CLASP2 TSC22D2 KMT2C UBR5 SGPL1 GLI3 PUM3 STRA6 NIPBL BAG6 CNOT2 MED12 FOXK1 TFEC POU2F1 CHD8 MED1 UNC50 SLC12A4 SLC25A39 ARID2 CDC25A ZMYM4 | 2.89e-08 | 1327 | 194 | 26 | 32694731 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BDP1 EPS8 USP9X MAML1 ARID1A ALMS1 UBR5 AGFG1 NAV1 SIPA1L2 FOXK1 SH3RF1 EP400 PIKFYVE YEATS2 ARID2 ZMYM4 | 4.04e-08 | 588 | 194 | 17 | 38580884 |
| Pubmed | MAML1 ZNF462 NIPBL TCF20 EP400 YEATS2 RACGAP1 CLINT1 ZNF281 HCFC1 ZMYM4 | 5.54e-08 | 222 | 194 | 11 | 37071664 | |
| Pubmed | 6.46e-08 | 8 | 194 | 4 | 11395011 | ||
| Pubmed | The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters. | 6.46e-08 | 8 | 194 | 4 | 24393035 | |
| Pubmed | Similar effects of all WNK3 variants on SLC12 cotransporters. | 6.46e-08 | 8 | 194 | 4 | 21613606 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ASXL1 MAML1 CASZ1 UBR5 NCAPD2 NFYA ADGRL2 FOXK1 NOTCH3 EP400 NUP98 POU2F1 DEPDC1 KMT2D DMKN FOXP1 ASXL2 CDC25A HCFC1 ZMYM4 | 8.32e-08 | 857 | 194 | 20 | 25609649 |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | UBL7 AMER1 UBR5 GLI3 NAV1 SIPA1L2 CHD8 SIPA1L1 SBF2 CDC25A ZNF281 | 8.66e-08 | 232 | 194 | 11 | 25515538 |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | ARID1A ZNF462 BAIAP2 EP400 NUP98 ADNP2 PUM2 CHD8 MED1 YEATS2 SRRM2 ZNF281 HCFC1 ZMYM4 | 9.20e-08 | 411 | 194 | 14 | 35182466 |
| Pubmed | SP1 SRF ARID1A HNF4A ZNF462 KMT2C GLI3 PLAG1 CNOT2 FOXK1 TBX15 SH3RF1 TCF20 POU2F1 MLLT10 PIKFYVE GMEB1 NFAT5 | 1.11e-07 | 709 | 194 | 18 | 22988430 | |
| Pubmed | 1.16e-07 | 9 | 194 | 4 | 19323993 | ||
| Pubmed | 1.16e-07 | 9 | 194 | 4 | 26416890 | ||
| Pubmed | 1.43e-07 | 43 | 194 | 6 | 33472061 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.45e-07 | 146 | 194 | 9 | 23892456 | |
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 34512623 | ||
| Pubmed | Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes. | 1.71e-07 | 3 | 194 | 3 | 26716708 | |
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 16412590 | ||
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 25835095 | ||
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 11551954 | ||
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 15262997 | ||
| Pubmed | K-Cl cotransporter gene expression during human and murine erythroid differentiation. | 1.71e-07 | 3 | 194 | 3 | 21733850 | |
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 24382590 | ||
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 33751773 | ||
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 1.83e-07 | 150 | 194 | 9 | 28242625 | |
| Pubmed | The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. | 1.92e-07 | 10 | 194 | 4 | 19815555 | |
| Pubmed | 2.05e-07 | 152 | 194 | 9 | 38360978 | ||
| Pubmed | EPS8 AMER1 USP9X CLASP2 ARID1A ARID1B ALMS1 UBR5 SGPL1 NAV1 BAIAP2 SIPA1L2 SH3RF1 SIPA1L1 | 2.48e-07 | 446 | 194 | 14 | 24255178 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SP1 ZNF609 CHD3 ARID1A CASZ1 PHF2 KMT2C WDR89 NIPBL FOXK1 TCF20 EP400 NUP98 MED1 RFX7 YEATS2 KMT2D RACGAP1 INTS4 ASXL2 SRRM2 ZNF281 HCFC1 ZMYM4 | 2.81e-07 | 1294 | 194 | 24 | 30804502 |
| Pubmed | 2.85e-07 | 78 | 194 | 7 | 28611094 | ||
| Pubmed | 3.08e-07 | 116 | 194 | 8 | 30804394 | ||
| Pubmed | ZNF609 VPS13C MAML1 KMT2C ARID1B USP38 NCAPD2 ADGRL2 WNK2 EP400 CHD8 IVNS1ABP RALGPS1 RACGAP1 ZMYM4 | 3.34e-07 | 529 | 194 | 15 | 14621295 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | EPS8 ARID1A MAP3K4 ZNF462 NIPBL CNOT2 MIER2 EPN2 HIPK3 USP6 TENM4 CSNK1G2 ARID2 SIPA1L1 FOXP1 | 3.94e-07 | 536 | 194 | 15 | 15840001 |
| Pubmed | ZNF609 USP9X ARID1B BRDT UBR5 NCAPD2 SIPA1L2 BAG6 TCF20 EP400 MUC16 YEATS2 ZNF281 | 4.07e-07 | 396 | 194 | 13 | 26687479 | |
| Pubmed | EPS8 ARID1A MAP3K4 ZNF462 NIPBL CNOT2 MIER2 EPN2 HIPK3 USP6 TENM4 CSNK1G2 ARID2 SIPA1L1 FOXP1 | 4.13e-07 | 538 | 194 | 15 | 10512203 | |
| Pubmed | ASXL1 USP9X CHD3 ARID1A NAV1 PLAG1 PARP9 ADGRL2 FOXK1 ANK1 CHD8 YEATS2 | 4.18e-07 | 332 | 194 | 12 | 37433992 | |
| Pubmed | VPS13C KMT2C PARP15 SLC12A6 TFEC TCF20 ADNP2 CSNK1G2 FOXP1 SPATA13 | 4.40e-07 | 217 | 194 | 10 | 34048709 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 4.83e-07 | 123 | 194 | 8 | 26912792 | |
| Pubmed | ZNF609 ZFYVE16 ARID1A ARID1B MED12 SMAP1 TCF20 EP400 CHD8 MED1 YEATS2 ARID2 RACGAP1 SRRM2 | 4.89e-07 | 472 | 194 | 14 | 38943005 | |
| Pubmed | NCOA3 USP9X CLASP2 ARHGEF11 NEK9 RTN1 SLC12A5 SYNGAP1 ZNF462 UBR5 NAV1 BAIAP2 NIPBL WNK2 TCF20 CHD8 FRY SIPA1L1 RACGAP1 SPATA13 | 5.26e-07 | 963 | 194 | 20 | 28671696 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | NCOA3 SP1 MAML1 HNF4A PHF2 GLI3 NFYA CNOT2 TBX15 LHX4 TCF20 POU2F1 MLLT10 MED1 IVNS1ABP GMEB1 DIP2C FOXP1 HCFC1 | 5.49e-07 | 877 | 194 | 19 | 20211142 |
| Pubmed | EPS8 ZNF609 USP9X CHD3 ARID1A ZNF462 UBR5 GLI3 NCAPD2 EP400 CHD8 | 6.08e-07 | 282 | 194 | 11 | 23667531 | |
| Pubmed | Loss of the tumor suppressor BAP1 causes myeloid transformation. | 6.45e-07 | 13 | 194 | 4 | 22878500 | |
| Pubmed | Oncogenic Truncations of ASXL1 Enhance a Motif for BRD4 ET-Domain Binding. | 6.81e-07 | 4 | 194 | 3 | 34536441 | |
| Pubmed | 6.81e-07 | 4 | 194 | 3 | 34645806 | ||
| Pubmed | 7.37e-07 | 130 | 194 | 8 | 12421765 | ||
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 9.28e-07 | 134 | 194 | 8 | 25452129 | |
| Pubmed | NCOA3 SP1 USP9X NCAPD2 FAM83G NIPBL BAG6 NUP98 CHD8 MED1 GMEB1 RACGAP1 SRRM2 HCFC1 | 1.04e-06 | 503 | 194 | 14 | 16964243 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | USP9X ARID1A MAP3K4 ARID1B UBR5 NUP210 PUM3 EP400 NUP98 CHD8 MED1 ARID2 ZBTB11 | 1.32e-06 | 440 | 194 | 13 | 34244565 |
| Pubmed | ZFYVE16 CHD3 FMNL2 ARID1B UBR5 PKD1 PLAG1 BAG6 EPN2 HIPK3 KMT2D SLC12A4 GMEB1 ASXL2 ZBTB11 | 1.33e-06 | 591 | 194 | 15 | 15231748 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | ZNF280A ZNF609 FOXK1 SMAP1 EP400 MED8 CHD8 MED1 YEATS2 CLINT1 ZNF281 HCFC1 ZMYM4 | 1.46e-06 | 444 | 194 | 13 | 34795231 |
| Pubmed | 1.62e-06 | 16 | 194 | 4 | 20805357 | ||
| Pubmed | Recent advances in understanding chromatin remodeling by Swi/Snf complexes. | 1.69e-06 | 5 | 194 | 3 | 12672490 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA3 SP1 CHD3 NIPBL BAG6 TCF20 EP400 NUP98 PUM2 POU2F1 MED1 RFX7 YEATS2 KMT2D SIPA1L1 SRRM2 ZMYM4 | 1.85e-06 | 774 | 194 | 17 | 15302935 |
| Pubmed | 1.90e-06 | 103 | 194 | 7 | 10574462 | ||
| Pubmed | ZNF609 ZFYVE16 USP9X CLASP2 ARID1A PHF2 ARID1B NUP210 BAIAP2 ADGRL2 NUP98 KMT2D SLC12A4 SBF2 INTS4 CLINT1 CDC25A SLC12A7 SRRM2 PLK4 | 1.95e-06 | 1049 | 194 | 20 | 27880917 | |
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 2.50e-06 | 69 | 194 | 6 | 28481362 | |
| Pubmed | 3.05e-06 | 157 | 194 | 8 | 30186101 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ZNF609 CASZ1 SYNGAP1 ZNF462 TSC22D1 ARID1B SGPL1 GLI3 NUP210 NCAPD2 BAG6 MED12 TCF20 CHD8 INTS8 WDR74 SRRM2 ZNF281 HCFC1 ZMYM4 CD276 | 4.21e-06 | 1203 | 194 | 21 | 29180619 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | VPS13C SYNC FMNL2 KMT2C ZFR2 EXOC3L4 PKD1 CDC42BPG ANK1 CDKL2 MUC19 IVNS1ABP FRY CSNK1G2 ZBTB11 SLC26A11 | 4.29e-06 | 736 | 194 | 16 | 29676528 |
| Pubmed | 5.84e-06 | 46 | 194 | 5 | 20301533 | ||
| Pubmed | Rare independent mutations in renal salt handling genes contribute to blood pressure variation. | 6.35e-06 | 22 | 194 | 4 | 18391953 | |
| Pubmed | Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. | 6.90e-06 | 125 | 194 | 7 | 32891193 | |
| Pubmed | 7.65e-06 | 23 | 194 | 4 | 9225980 | ||
| Pubmed | Composite co-activator ARC mediates chromatin-directed transcriptional activation. | 7.65e-06 | 23 | 194 | 4 | 10235267 | |
| Interaction | FEV interactions | NCOA3 ZNF609 MAML1 ARID1A ZNF462 KMT2C ARID1B NIPBL FOXK1 TCF20 EP400 POU2F1 MLLT10 KMT2D ARID2 FOXP1 ASXL2 ZNF281 ZMYM4 | 9.30e-14 | 203 | 193 | 19 | int:FEV |
| Interaction | HNF4A interactions | NCOA3 SP1 ZNF609 CHD3 ARID1A HNF4A ZNF462 KMT2C ARID1B NIPBL EP400 MED8 MUC19 MED1 YEATS2 KMT2D ARID2 FOXP1 ASXL2 ZNF281 ZMYM4 | 2.46e-13 | 275 | 193 | 21 | int:HNF4A |
| Interaction | CRX interactions | NCOA3 SP1 ZNF609 MAML1 ARID1A ZNF462 KMT2C ARID1B NIPBL MED12 FOXK1 SMAP1 TCF20 EP400 POU2F1 KMT2D ARID2 FOXP1 ASXL2 ZMYM4 | 5.31e-13 | 254 | 193 | 20 | int:CRX |
| Interaction | AR interactions | NCOA3 SP1 ASXL1 ZNF609 VPS13C MAML1 CHD3 ARID1A HNF4A NEK9 CASZ1 ZNF462 KMT2C ARID1B UBR5 GLI3 NIPBL BAG6 MED12 FOXK1 CDC42BPG TCF20 EP400 MED8 POU2F1 CHD8 MED1 HIPK3 KMT2D ARID2 INTS4 FOXP1 TNS4 CDC25A ZNF281 HCFC1 ZMYM4 | 8.79e-13 | 992 | 193 | 37 | int:AR |
| Interaction | SOX7 interactions | NCOA3 ZNF609 MAML1 ARID1A CASZ1 KMT2C ARID1B TCF20 ADNP2 KMT2D ARID2 FOXP1 | 1.95e-11 | 82 | 193 | 12 | int:SOX7 |
| Interaction | HNF1B interactions | NCOA3 ZNF609 MAML1 ARID1A KMT2C ARID1B NIPBL LHX4 EP400 MLLT10 KMT2D ARID2 FOXP1 ASXL2 ZNF281 ZMYM4 | 4.50e-11 | 190 | 193 | 16 | int:HNF1B |
| Interaction | KLF5 interactions | NCOA3 ZNF609 MAML1 ARID1A KMT2C ARID1B NIPBL FOXK1 EP400 MLLT10 KMT2D ARID2 FOXP1 ZNF281 HCFC1 ZMYM4 | 6.65e-11 | 195 | 193 | 16 | int:KLF5 |
| Interaction | TBXT interactions | NCOA3 ZNF609 MAML1 ARID1A KMT2C ARID1B NIPBL TCF20 MED8 KMT2D FOXP1 ZNF281 ZMYM4 | 8.83e-11 | 116 | 193 | 13 | int:TBXT |
| Interaction | EGR2 interactions | NCOA3 ZNF609 MAML1 ARID1A ZNF462 KMT2C ARID1B NIPBL EP400 KMT2D ARID2 FOXP1 ZNF281 HCFC1 ZMYM4 | 1.04e-10 | 171 | 193 | 15 | int:EGR2 |
| Interaction | TLX1 interactions | NCOA3 ZNF609 MAML1 ARID1A ZNF462 KMT2C ARID1B NIPBL FOXK1 TCF20 KMT2D FOXP1 ASXL2 ZNF281 ZMYM4 | 1.45e-10 | 175 | 193 | 15 | int:TLX1 |
| Interaction | NUP43 interactions | ZNF609 CHD3 ARID1A SUCLG1 ZNF462 PHF2 ARID1B UBR5 BAIAP2 NIPBL MED12 CENPT TCF20 EP400 NUP98 MUC19 CHD8 YEATS2 KMT2D ARID2 ASXL2 ZBTB11 SRRM2 ZNF281 HCFC1 ZMYM4 | 3.18e-10 | 625 | 193 | 26 | int:NUP43 |
| Interaction | TLX3 interactions | NCOA3 SP1 ZNF609 MAML1 ARID1A SYNGAP1 KMT2C ARID1B NIPBL FOXK1 TBX15 TCF20 POU2F1 KMT2D ARID2 FOXP1 TOX2 ZNF281 | 4.34e-10 | 291 | 193 | 18 | int:TLX3 |
| Interaction | ERG interactions | NCOA3 ZNF609 USP9X MAML1 ARID1A KMT2C ARID1B UBR5 NIPBL TCF20 MLLT10 KMT2D FOXP1 ASXL2 ZNF281 | 4.21e-09 | 223 | 193 | 15 | int:ERG |
| Interaction | IRF4 interactions | NCOA3 ZNF609 ARID1A KMT2C ARID1B NIPBL TCF20 KMT2D ARID2 FOXP1 | 8.62e-09 | 85 | 193 | 10 | int:IRF4 |
| Interaction | TEAD1 interactions | ZNF609 SRF CHD3 ARID1A ZNF462 KMT2C ARID1B NIPBL KMT2D ARID2 FOXP1 ASXL2 ZNF281 | 1.54e-08 | 176 | 193 | 13 | int:TEAD1 |
| Interaction | SOX17 interactions | NCOA3 ZNF609 ARID1A KMT2C ARID1B TCF20 POU2F1 KMT2D ARID2 ZNF281 | 2.56e-08 | 95 | 193 | 10 | int:SOX17 |
| Interaction | CEBPA interactions | NCOA3 ASXL1 ZNF609 MAML1 CHD3 ARID1A PHF2 KMT2C ARID1B UBR5 NFYA PUM3 NIPBL BAG6 MED12 FOXK1 TCF20 EP400 MED8 POU2F1 CHD8 MED1 WDR74 YEATS2 KMT2D ARID2 GMEB1 FOXP1 ASXL2 CLINT1 SRRM2 ZNF281 HCFC1 ZMYM4 | 2.78e-08 | 1245 | 193 | 34 | int:CEBPA |
| Interaction | SOX9 interactions | NCOA3 ZNF609 ARID1A KMT2C ARID1B MED12 EP400 KMT2D ARID2 ZNF281 | 3.14e-08 | 97 | 193 | 10 | int:SOX9 |
| Interaction | SP7 interactions | NCOA3 ZNF609 MAML1 CHD3 ARID1A KMT2C ARID1B NIPBL FOXK1 TCF20 EP400 POU2F1 KMT2D ARID2 FOXP1 ZNF281 | 4.11e-08 | 304 | 193 | 16 | int:SP7 |
| Interaction | NFIX interactions | ZNF609 SRF ARID1A KMT2C ARID1B NIPBL LHX4 EP400 POU2F1 KMT2D ARID2 FOXP1 ZNF281 ZMYM4 | 4.21e-08 | 227 | 193 | 14 | int:NFIX |
| Interaction | MEN1 interactions | ZNF609 CHD3 ARID1A ZNF462 KMT2C ARID1B UBR5 SGPL1 NUP210 NCAPD2 PUM3 CNOT2 MED12 FOXK1 TCF20 EP400 NUP98 CHD8 MED1 INTS8 UNC50 KMT2D ARID2 RACGAP1 FOXP1 SRRM2 CSNK2A3 ZNF281 HCFC1 ZMYM4 | 4.96e-08 | 1029 | 193 | 30 | int:MEN1 |
| Interaction | PAX9 interactions | NCOA3 ZNF609 MAML1 ARID1A KMT2C ARID1B NIPBL FOXK1 TCF20 KMT2D FOXP1 | 5.04e-08 | 130 | 193 | 11 | int:PAX9 |
| Interaction | KDM6A interactions | ASXL1 SRF HNF4A KMT2C FOXK1 LHX4 YEATS2 KMT2D ASXL3 ASXL2 ZNF281 HCFC1 | 5.43e-08 | 162 | 193 | 12 | int:KDM6A |
| Interaction | PAX6 interactions | NCOA3 ZNF609 CHD3 ARID1A ZNF462 KMT2C ARID1B NIPBL FOXK1 EP400 POU2F1 KMT2D ARID2 FOXP1 ASXL2 ZNF281 ZMYM4 | 9.38e-08 | 366 | 193 | 17 | int:PAX6 |
| Interaction | SOX15 interactions | NCOA3 ZNF609 ARID1A ARID1B FOXK1 POU2F1 KMT2D ARID2 FOXP1 SRRM2 ZNF281 | 1.16e-07 | 141 | 193 | 11 | int:SOX15 |
| Interaction | NFIB interactions | NCOA3 ZNF609 MAML1 ARID1A HNF4A KMT2C ARID1B LHX4 KMT2D FOXP1 ZNF281 | 1.25e-07 | 142 | 193 | 11 | int:NFIB |
| Interaction | TBR1 interactions | NCOA3 ZNF609 MAML1 ARID1A KMT2C ARID1B BRDT FOXK1 KMT2D ZMYM4 | 1.36e-07 | 113 | 193 | 10 | int:TBR1 |
| Interaction | TLE3 interactions | NCOA3 ZNF609 MAML1 ARID1A ARID1B UBR5 NIPBL TBX15 TCF20 MLLT10 KMT2D ARID2 RAVER2 INTS4 ASXL2 SRRM2 ZNF281 | 1.38e-07 | 376 | 193 | 17 | int:TLE3 |
| Interaction | GSC interactions | 1.51e-07 | 87 | 193 | 9 | int:GSC | |
| Interaction | SOX2 interactions | NCOA3 EPS8 ZNF609 USP9X MAML1 CHD3 ARID1A ZNF462 KMT2C ARID1B KIDINS220 UBR5 GLI3 NCAPD2 PUM3 SIPA1L2 NIPBL FOXK1 PTBP3 TCF20 EP400 NUP98 PUM2 POU2F1 CHD8 MED1 KMT2D DMKN ARID2 SIPA1L1 FOXP1 CLINT1 TNS4 ZNF281 EPHA7 | 2.14e-07 | 1422 | 193 | 35 | int:SOX2 |
| Interaction | FOXI1 interactions | 2.46e-07 | 92 | 193 | 9 | int:FOXI1 | |
| Interaction | ESRRB interactions | NCOA3 SP1 SYNC ARID1A ZNF462 KMT2C SGPL1 MED12 EP400 MED8 MED1 KMT2D ZNF281 HCFC1 | 2.48e-07 | 262 | 193 | 14 | int:ESRRB |
| Interaction | KLF3 interactions | ZNF609 CHD3 ARID1A ARID1B NIPBL FOXK1 EP400 RFX7 KMT2D ARID2 FOXP1 ZNF281 ZMYM4 | 3.22e-07 | 228 | 193 | 13 | int:KLF3 |
| Interaction | PAX7 interactions | NCOA3 ZNF609 MAML1 ARID1A KMT2C ARID1B POU2F1 KMT2D FOXP1 ZNF281 | 3.26e-07 | 124 | 193 | 10 | int:PAX7 |
| Interaction | MYOD1 interactions | NCOA3 SP1 ZNF609 SRF ARID1A KMT2C ARID1B NIPBL EP400 MED8 KMT2D ZNF281 | 3.88e-07 | 194 | 193 | 12 | int:MYOD1 |
| Interaction | GATA2 interactions | NCOA3 ZNF609 ARID1A KMT2C ARID1B NIPBL MED1 KMT2D ARID2 FOXP1 ASXL2 ZNF281 | 5.10e-07 | 199 | 193 | 12 | int:GATA2 |
| Interaction | ASF1A interactions | BDP1 ARID1A CASZ1 PHF2 ARID1B TCF20 EP400 CHD8 YEATS2 KMT2D ARID2 ZNF281 HCFC1 | 8.75e-07 | 249 | 193 | 13 | int:ASF1A |
| Interaction | NANOG interactions | SP1 ZNF609 USP9X ARID1A ZNF462 KMT2C ARID1B NCAPD2 SIPA1L2 MED12 TCF20 EP400 MUC16 PUM2 YEATS2 INTS4 ZNF281 HCFC1 | 9.38e-07 | 481 | 193 | 18 | int:NANOG |
| Interaction | TLX2 interactions | ZNF609 ARID1A KMT2C ARID1B PUM3 NIPBL TCF20 POU2F1 KMT2D ZNF281 | 1.14e-06 | 142 | 193 | 10 | int:TLX2 |
| Interaction | PAX8 interactions | 1.23e-06 | 111 | 193 | 9 | int:PAX8 | |
| Interaction | LHX2 interactions | ZNF609 ARID1A PHF2 KMT2C ARID1B FOXK1 EP400 KMT2D ARID2 FOXP1 ZMYM4 | 1.59e-06 | 183 | 193 | 11 | int:LHX2 |
| Interaction | LHX3 interactions | ZNF609 ARID1A KMT2C ARID1B NIPBL FOXK1 TCF20 KMT2D ARID2 INTS4 FOXP1 | 1.77e-06 | 185 | 193 | 11 | int:LHX3 |
| Interaction | HDAC1 interactions | SP1 ZNF609 ZFYVE16 CHD3 ARID1A NEK9 CASZ1 ALMS1 USP38 UBR5 GLI3 NCAPD2 NFYA NAV1 MED12 FOXK1 MIER2 TCF20 EP400 MED8 NUP98 POU2F1 CHD8 YEATS2 KMT2D ZBTB11 CSNK2A3 HCFC1 | 2.51e-06 | 1108 | 193 | 28 | int:HDAC1 |
| Interaction | SOX10 interactions | 2.87e-06 | 92 | 193 | 8 | int:SOX10 | |
| Interaction | H3-3A interactions | CHD3 HNF4A CASZ1 PHF2 KMT2C PUM3 NIPBL FOXK1 CENPT TCF20 ADNP2 POU2F1 CHD8 MED1 PARP10 KMT2D ARID2 RACGAP1 ZBTB11 ZNF281 HCFC1 ZMYM4 | 3.17e-06 | 749 | 193 | 22 | int:H3-3A |
| Interaction | NUP35 interactions | NCOA3 ZNF609 MAML1 ARID1A KMT2C ARID1B NUP210 STRA6 CNOT2 FOXK1 TCF20 NUP98 PUM2 YEATS2 KMT2D RAVER2 | 3.48e-06 | 424 | 193 | 16 | int:NUP35 |
| Interaction | POU5F1 interactions | SP1 USP9X CHD3 ARID1A ZNF462 ARID1B BRDT UBR5 NCAPD2 SIPA1L2 BAG6 TCF20 EP400 MUC16 MLLT10 YEATS2 TOX2 ZNF281 HCFC1 | 3.64e-06 | 584 | 193 | 19 | int:POU5F1 |
| Interaction | GCM1 interactions | 3.92e-06 | 68 | 193 | 7 | int:GCM1 | |
| Interaction | CXXC1 interactions | 5.18e-06 | 132 | 193 | 9 | int:CXXC1 | |
| Interaction | HCFC1 interactions | SP1 ASXL1 ITGB3 KMT2C FOXK1 EP400 POU2F1 CHD8 YEATS2 KMT2D ASXL3 ASXL2 HCFC1 | 5.28e-06 | 293 | 193 | 13 | int:HCFC1 |
| Interaction | KMT2C interactions | 5.86e-06 | 134 | 193 | 9 | int:KMT2C | |
| Interaction | YWHAH interactions | NCOA3 AMER1 CLASP2 SYNGAP1 ALMS1 AGFG1 NAV1 FAM83G BAIAP2 SIPA1L2 FOXK1 WNK2 CDC42BPG SH3RF1 TCF20 STIL MED1 RFX7 EPN2 IVNS1ABP SIPA1L1 RACGAP1 CLINT1 CDC25A SRRM2 PLK4 SPATA13 | 6.83e-06 | 1102 | 193 | 27 | int:YWHAH |
| Interaction | FBXO42 interactions | BDP1 EPS8 USP9X ARID1A ALMS1 AGFG1 NAV1 SH3RF1 EP400 PIKFYVE YEATS2 ARID2 | 7.92e-06 | 259 | 193 | 12 | int:FBXO42 |
| Interaction | NFYC interactions | 8.27e-06 | 177 | 193 | 10 | int:NFYC | |
| Interaction | PHF20 interactions | 1.13e-05 | 53 | 193 | 6 | int:PHF20 | |
| Interaction | SMG7 interactions | NCOA3 ZNF609 MAML1 ARID1A ARID1B CNOT2 TCF20 CHD8 TNRC6C STIL MLLT10 YEATS2 KMT2D | 1.31e-05 | 319 | 193 | 13 | int:SMG7 |
| Interaction | NFIA interactions | NCOA3 ZNF609 MAML1 ARID1A HNF4A ARID1B LHX4 KMT2D FOXP1 ZNF281 | 1.40e-05 | 188 | 193 | 10 | int:NFIA |
| Interaction | PAX2 interactions | 1.74e-05 | 85 | 193 | 7 | int:PAX2 | |
| Interaction | KLF8 interactions | NCOA3 SP1 ZNF609 NIPBL FOXK1 EP400 POU2F1 YEATS2 KMT2D ARID2 FOXP1 ZNF281 ZMYM4 | 1.82e-05 | 329 | 193 | 13 | int:KLF8 |
| Interaction | KLF4 interactions | 2.44e-05 | 160 | 193 | 9 | int:KLF4 | |
| Interaction | KLF15 interactions | NCOA3 ZNF609 MAML1 KMT2C NIPBL FOXK1 EP400 KMT2D ARID2 GMEB1 ZNF281 ZMYM4 | 2.45e-05 | 290 | 193 | 12 | int:KLF15 |
| Interaction | TOP3B interactions | MAML1 CLASP2 ARID1A ARHGEF11 CASZ1 KMT2C PKD1 NCAPD2 NAV1 SIPA1L2 CNOT2 MED12 FOXK1 WNK2 SH3RF1 EP400 CHD8 TNRC6C MLLT10 PIKFYVE KMT2D SLC12A4 SLC25A39 CSNK1G2 RALGPS1 SBF2 DIP2C RACGAP1 HCFC1 SPATA13 CD276 | 2.65e-05 | 1470 | 193 | 31 | int:TOP3B |
| Interaction | SOX5 interactions | 2.69e-05 | 162 | 193 | 9 | int:SOX5 | |
| Interaction | FHL2 interactions | SP1 AMER1 SRF ALMS1 CNOT2 FOXK1 SH3RF1 EP400 YEATS2 SLC34A1 FOXP1 ASXL2 NFAT5 ZMYM4 | 2.97e-05 | 396 | 193 | 14 | int:FHL2 |
| Interaction | FASN interactions | SP1 ASXL1 ZNF609 USP9X CLASP2 TSC22D2 KMT2C USP38 SGPL1 GLI3 PUM3 STRA6 NIPBL BAG6 CNOT2 MED12 VCAM1 POU2F1 CHD8 MED1 ASXL3 ARID2 ASXL2 CDC25A ZMYM4 | 3.01e-05 | 1062 | 193 | 25 | int:FASN |
| Interaction | LHX4 interactions | 3.27e-05 | 166 | 193 | 9 | int:LHX4 | |
| Interaction | NFIC interactions | NCOA3 ZNF609 ARID1A ARID1B LHX4 POU2F1 KMT2D FOXP1 ZNF281 ZMYM4 | 3.63e-05 | 210 | 193 | 10 | int:NFIC |
| Interaction | SUPT5H interactions | CHD3 ARID1A ITGB3 PHF2 ARID1B UBR5 FGF12 NIPBL TCF20 EP400 INTS8 KMT2D INTS4 ZMYM4 | 4.11e-05 | 408 | 193 | 14 | int:SUPT5H |
| Interaction | HBG1 interactions | 4.30e-05 | 21 | 193 | 4 | int:HBG1 | |
| Interaction | SNRNP40 interactions | ZNF609 CHD3 ARID1A ZNF462 ARID1B UBR5 MED12 CENPT TCF20 EP400 ADNP2 YEATS2 ARID2 RAVER2 INTS4 ZBTB11 SRRM2 ZNF281 | 4.34e-05 | 637 | 193 | 18 | int:SNRNP40 |
| Interaction | ETV4 interactions | 5.18e-05 | 69 | 193 | 6 | int:ETV4 | |
| Interaction | FBXO22 interactions | BDP1 USP9X CLASP2 ARHGEF11 MAP3K4 SYNGAP1 KMT2C NCAPD2 METTL17 BAG6 MED12 ANK1 WDR74 ARID2 CSNK2A3 HCFC1 | 6.73e-05 | 540 | 193 | 16 | int:FBXO22 |
| Interaction | FBXO38 interactions | 7.96e-05 | 145 | 193 | 8 | int:FBXO38 | |
| Interaction | GATA3 interactions | 8.24e-05 | 187 | 193 | 9 | int:GATA3 | |
| Interaction | ZYX interactions | UBL7 USP9X TSC22D2 RTN1 KIDINS220 ALMS1 SIPA1L2 VCAM1 SH3RF1 HIPK3 SIPA1L1 RACGAP1 | 8.27e-05 | 329 | 193 | 12 | int:ZYX |
| Interaction | TERF2IP interactions | ZNF609 ARPP21 CHD3 ARID1A NIPBL TCF20 EP400 CHD8 MED1 PRX YEATS2 RACGAP1 SRRM2 ZNF281 HCFC1 ZMYM4 | 8.70e-05 | 552 | 193 | 16 | int:TERF2IP |
| Interaction | H3C3 interactions | CHD3 ZNF462 PHF2 PUM3 NIPBL MIER2 TCF20 ADNP2 POU2F1 CHD8 MED1 ARID2 RACGAP1 ZNF281 ZMYM4 | 8.91e-05 | 495 | 193 | 15 | int:H3C3 |
| Interaction | EN1 interactions | 9.18e-05 | 110 | 193 | 7 | int:EN1 | |
| Interaction | SYNE3 interactions | VPS13C RTN1 KIDINS220 ALMS1 GLI3 NUP210 NAV1 SIPA1L2 TCF20 NUP98 TNRC6C STIL YEATS2 SIPA1L1 | 1.01e-04 | 444 | 193 | 14 | int:SYNE3 |
| Interaction | KDM1A interactions | ZNF280A NCOA3 ZNF609 ZFYVE16 USP9X CHD3 HNF4A NEK9 ZNF462 ALMS1 USP38 UBR5 NAV1 BAIAP2 MED12 TCF20 EP400 CHD8 YEATS2 KMT2D FOXP1 ZMYM4 | 1.03e-04 | 941 | 193 | 22 | int:KDM1A |
| Interaction | CTNNB1 interactions | SP1 AMER1 USP9X SUCLG1 HNF4A FMNL2 SYNGAP1 TSC22D1 UBR5 PKD1 NFYA SIPA1L2 CNOT2 EP400 NUP98 CHD8 MLLT10 KMT2D SIPA1L1 FOXP1 ASXL2 SRRM2 EPHA7 | 1.04e-04 | 1009 | 193 | 23 | int:CTNNB1 |
| Interaction | HNF1A interactions | 1.19e-04 | 80 | 193 | 6 | int:HNF1A | |
| Interaction | SIRT6 interactions | USP9X CHD3 ARID1A MAP3K4 ARID1B UBR5 NUP210 NCAPD2 PUM3 BAG6 MED12 EP400 NUP98 CHD8 MED1 ARID2 ZBTB11 | 1.20e-04 | 628 | 193 | 17 | int:SIRT6 |
| Interaction | ELF4 interactions | 1.21e-04 | 115 | 193 | 7 | int:ELF4 | |
| Interaction | PPIA interactions | ASXL1 ZNF609 ZFYVE16 ARID1A SYNGAP1 ARID1B MED12 VCAM1 NOTCH3 SMAP1 TCF20 EP400 POU2F1 CHD8 MED1 YEATS2 ARID2 RACGAP1 ASXL2 SRRM2 HCFC1 | 1.28e-04 | 888 | 193 | 21 | int:PPIA |
| Interaction | YY1 interactions | SP1 ASXL1 CHD3 HNF4A METTL17 LHX4 EP400 CHD8 YEATS2 ARID2 FOXP1 ASXL2 HCFC1 ZMYM4 | 1.28e-04 | 454 | 193 | 14 | int:YY1 |
| Interaction | ELF2 interactions | 1.33e-04 | 156 | 193 | 8 | int:ELF2 | |
| Interaction | SOX6 interactions | 1.39e-04 | 157 | 193 | 8 | int:SOX6 | |
| Interaction | ETS1 interactions | 1.67e-04 | 121 | 193 | 7 | int:ETS1 | |
| Interaction | NR3C1 interactions | NCOA3 SP1 USP9X MAML1 ARID1A CASZ1 ARID1B NUP210 NIPBL TCF20 MED8 NUP98 MUC16 POU2F1 MED1 YEATS2 USP6 KMT2D ASXL3 ARID2 TNS4 ZNF281 | 1.69e-04 | 974 | 193 | 22 | int:NR3C1 |
| Interaction | RHOB interactions | EPS8 AMER1 ZFYVE16 USP9X ARHGEF11 FMNL2 KIDINS220 AGFG1 BAIAP2 SIPA1L2 ADGRL2 SLC12A6 DEPDC1 EPN2 SLC12A4 SIPA1L1 SLC22A4 RACGAP1 SLC12A7 EPHA7 | 1.70e-04 | 840 | 193 | 20 | int:RHOB |
| Interaction | TBP interactions | 1.70e-04 | 253 | 193 | 10 | int:TBP | |
| Interaction | MKI67 interactions | SP1 CHD3 PUM3 BAIAP2 METTL17 NIPBL MED12 EP400 CDKL2 CHD8 WDR74 KMT2D SIPA1L1 RACGAP1 PLK4 HCFC1 ZMYM4 | 1.74e-04 | 648 | 193 | 17 | int:MKI67 |
| Interaction | KANSL3 interactions | 1.78e-04 | 86 | 193 | 6 | int:KANSL3 | |
| Interaction | FBXW11 interactions | UBL7 AMER1 UBR5 GLI3 NAV1 SIPA1L2 CHD8 STIL SIPA1L1 SBF2 CDC25A ZNF281 PLK4 HCFC1 | 1.96e-04 | 473 | 193 | 14 | int:FBXW11 |
| Interaction | TPRX2 interactions | 1.97e-04 | 56 | 193 | 5 | int:TPRX2 | |
| Interaction | EEF1AKMT3 interactions | VPS13C NEK9 NCAPD2 NAV1 BAG6 FOXK1 WNK2 PTBP3 CDC42BPG WDR74 SBF2 ZMYM4 | 2.12e-04 | 364 | 193 | 12 | int:EEF1AKMT3 |
| Interaction | ELF1 interactions | 2.14e-04 | 126 | 193 | 7 | int:ELF1 | |
| Interaction | MAPK3 interactions | SP1 MYLK ADAM15 HNF4A ITGB3 SYNGAP1 UBR5 NCAPD2 NGFR BAG6 MED1 RFX7 PRX | 2.20e-04 | 421 | 193 | 13 | int:MAPK3 |
| Interaction | CREBBP interactions | NCOA3 SP1 MAML1 SRF CLASP2 CHD3 ARID1A HNF4A ARID1B GLI3 NFYA NUP98 HIPK3 KMT2D GMEB1 CDC25A | 2.21e-04 | 599 | 193 | 16 | int:CREBBP |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 6.93e-07 | 25 | 125 | 5 | 775 | |
| GeneFamily | CD molecules|Mucins | 1.19e-05 | 21 | 125 | 4 | 648 | |
| GeneFamily | AT-rich interaction domain containing | 1.38e-04 | 15 | 125 | 3 | 418 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 2.04e-04 | 17 | 125 | 3 | 684 | |
| GeneFamily | PHD finger proteins | 4.01e-04 | 90 | 125 | 5 | 88 | |
| GeneFamily | Cyclins|Mediator complex | 1.51e-03 | 33 | 125 | 3 | 1061 | |
| GeneFamily | Solute carriers | SLC12A5 SLC12A6 SLC12A4 SLC34A1 SLC25A39 SLC22A4 SLC24A1 SLC12A7 SLC26A11 | 1.71e-03 | 395 | 125 | 9 | 752 |
| GeneFamily | ATAC complex | 3.52e-03 | 13 | 125 | 2 | 1058 | |
| GeneFamily | Integrator complex | 4.69e-03 | 15 | 125 | 2 | 1366 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | SP1 ASXL1 USP9X VPS13C ARID1A KMT2C NCAPD2 STIL RFX7 YEATS2 SIPA1L1 NFAT5 TOX2 HCFC1 | 8.08e-11 | 180 | 194 | 14 | M8239 |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN | MAP3K4 ARID1B ADGRL2 METTL17 NOTCH3 SLC12A6 CDC42BPG SH3RF1 CHD8 IVNS1ABP KMT2D TNS4 NFAT5 | 3.32e-09 | 199 | 194 | 13 | M7319 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BDP1 NCOA3 ZNF609 USP9X VPS13C ZNF683 CHD3 ARID1A NEK9 KMT2C KIDINS220 UBR5 NUP210 AGFG1 SLA2 PARP9 NIPBL CNOT2 IL27RA PTBP3 EP400 NUP98 PUM2 TNRC6C MED1 RFX7 IVNS1ABP PIKFYVE KMT2D CSNK1G2 ARID2 ASXL2 NFAT5 SPATA13 | 4.42e-09 | 1492 | 194 | 34 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA3 EPS8 ASXL1 ZFYVE16 USP9X CLASP2 TSC22D2 MAP3K4 KIDINS220 UBR5 AGFG1 PUM3 NIPBL CNOT2 NUP98 PUM2 STIL MED1 PIKFYVE USP6 SIPA1L1 CLINT1 ZBTB11 ZMYM4 | 2.43e-08 | 856 | 194 | 24 | M4500 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | BDP1 ARPP21 BACE1 CHD3 FMNL2 RTN1 CASZ1 SLC12A5 ZNF462 NAV1 FGF12 PTBP3 ANK1 CDKL2 MUC19 POU2F1 TNRC6C RFX7 FRY CSNK1G2 RALGPS1 ASXL3 SBF2 SLC22A4 TOX2 SPATA13 | 2.00e-07 | 1106 | 194 | 26 | M39071 |
| Coexpression | GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP | SP1 UBR5 PKD1 IL27RA PUM2 MED1 RFX7 ASXL2 ZBTB11 ZNF281 ZMYM4 | 3.16e-07 | 200 | 194 | 11 | M3419 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | ZFYVE16 MAP3K4 NUP210 NCAPD2 NAV1 TNRC6C IVNS1ABP FRY ASXL2 NFAT5 | 4.78e-07 | 166 | 194 | 10 | M6826 |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_UP | MAML1 FMNL2 AGFG1 FPR1 POU2F1 LCAT SLC12A4 SIPA1L1 CLINT1 NFAT5 | 7.77e-07 | 175 | 194 | 10 | M6723 |
| Coexpression | GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_DN | EPS8 SP1 SRF SUCLG1 UBR5 CDC42BPG POU2F1 SLC12A4 SLC25A39 ARID2 | 2.60e-06 | 200 | 194 | 10 | M9479 |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | USP9X CHD3 TSC22D2 BAIAP2 NIPBL BAG6 SMAP1 TCF20 PUM2 FOXP1 ASXL2 SRRM2 ZMYM4 | 9.50e-06 | 399 | 194 | 13 | M41172 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | NCOA3 ASXL1 MAML1 UBR5 NFYA ADGRL2 CNOT2 PUM2 PIKFYVE USP6 PLK4 | 1.59e-05 | 300 | 194 | 11 | M8702 |
| Coexpression | GSE17721_LPS_VS_CPG_0.5H_BMDC_UP | 1.78e-05 | 198 | 194 | 9 | M3982 | |
| Coexpression | GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN | 1.86e-05 | 199 | 194 | 9 | M3177 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | BDP1 ARPP21 LRRTM3 RTN1 CASZ1 SLC12A5 ZNF462 LRRTM4 ANK1 CDKL2 MUC19 TNRC6C FRY TENM4 RALGPS1 ASXL3 TOX2 | 2.06e-05 | 703 | 194 | 17 | M39070 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN | UBL7 ELAPOR2 TSC22D2 ARID1A NFYA NAV1 CNOT2 FOXK1 TBX15 TCF20 SIPA1L1 SBF2 CLINT1 | 2.53e-05 | 438 | 194 | 13 | M227 |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | VPS13C LINC00305 SRF CLASP2 ZNF462 KMT2C KIDINS220 NAV1 SIPA1L2 ADGRL2 METTL17 CNOT2 WNK2 ANK1 DMKN SBF2 FOXP1 TNS4 ZMYM4 | 2.84e-05 | 873 | 194 | 19 | M16009 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | NCOA3 EPS8 USP9X CLASP2 UBR5 PUM3 CNOT2 NUP98 PUM2 STIL PIKFYVE USP6 ZMYM4 | 4.78e-05 | 466 | 194 | 13 | M13522 |
| Coexpression | GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN | 5.91e-05 | 179 | 194 | 8 | M6689 | |
| Coexpression | GENTILE_UV_HIGH_DOSE_DN | 6.29e-05 | 289 | 194 | 10 | M13630 | |
| Coexpression | HEVNER_CORTICAL_PLATE_POSTMITOTIC_NEURONS | 7.13e-05 | 136 | 194 | 7 | MM407 | |
| Coexpression | BENPORATH_CYCLING_GENES | NCOA3 ASXL1 SRF ITGB3 TSC22D1 NCAPD2 AGFG1 BAIAP2 NIPBL VCAM1 NUP98 STIL IVNS1ABP CDC25A ZNF281 | 1.04e-04 | 648 | 194 | 15 | M8156 |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 1.19e-04 | 198 | 194 | 8 | M8624 | |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 1.24e-04 | 199 | 194 | 8 | M9443 | |
| Coexpression | GSE17721_CTRL_VS_CPG_0.5H_BMDC_UP | 1.24e-04 | 199 | 194 | 8 | M3754 | |
| Coexpression | GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_DN | 1.24e-04 | 199 | 194 | 8 | M5107 | |
| Coexpression | KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_DN | 1.24e-04 | 199 | 194 | 8 | M3028 | |
| Coexpression | GENTILE_UV_RESPONSE_CLUSTER_D5 | 1.27e-04 | 35 | 194 | 4 | M13814 | |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 1.28e-04 | 200 | 194 | 8 | M9439 | |
| Coexpression | GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP | 1.28e-04 | 200 | 194 | 8 | M3413 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_2H_BMDC_DN | 1.28e-04 | 200 | 194 | 8 | M3939 | |
| Coexpression | GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_UP | 1.28e-04 | 200 | 194 | 8 | M5087 | |
| Coexpression | GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN | 1.28e-04 | 200 | 194 | 8 | M9260 | |
| Coexpression | KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_DN | 1.28e-04 | 200 | 194 | 8 | M3025 | |
| Coexpression | GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP | 1.43e-04 | 152 | 194 | 7 | M2938 | |
| Coexpression | PEREZ_TP53_AND_TP63_TARGETS | 1.62e-04 | 207 | 194 | 8 | M14566 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP | NCOA3 EPS8 SYNC ARID1A EFEMP1 ALMS1 NCAPD2 PLAG1 PTBP3 NUP98 MED1 | 1.63e-04 | 389 | 194 | 11 | M6520 |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | VPS13C CHD3 TSC22D2 ARID1A CASZ1 ZNF462 KMT2C TSC22D1 SGPL1 GTF2IRD2 WDR89 METTL17 PTBP3 SH3RF1 EPN2 IVNS1ABP ARID2 | 1.89e-04 | 843 | 194 | 17 | M2356 |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP | 2.46e-04 | 166 | 194 | 7 | M7009 | |
| Coexpression | COLLIS_PRKDC_SUBSTRATES | 2.51e-04 | 17 | 194 | 3 | M4495 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 2.74e-04 | 169 | 194 | 7 | M39230 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | ZNF609 USP9X NEK9 TSC22D1 UBR5 NUP210 NIPBL BAG6 IL27RA PTBP3 SMAP1 NUP98 PUM2 HIPK3 CUTC USP6 ASXL2 SLC24A1 NFAT5 PLK4 ZMYM4 | 2.79e-04 | 1215 | 194 | 21 | M41122 |
| Coexpression | GUO_HEX_TARGETS_UP | 2.87e-04 | 78 | 194 | 5 | M1436 | |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | ARPP21 SYNGAP1 ZFR2 PKD1 NAV1 FGF12 BAIAP2 TNRC6C IVNS1ABP TENM4 RALGPS1 FOXP1 | 3.00e-04 | 488 | 194 | 12 | M39104 |
| Coexpression | GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_UP | 3.05e-04 | 172 | 194 | 7 | M2951 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | USP9X BACE1 CLASP2 GLI3 PLAG1 PUM2 MED1 HIPK3 TENM4 ASXL3 FOXP1 ASXL2 ZMYM4 EPHA7 | 1.16e-05 | 385 | 192 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | VPS13C FMNL2 CASZ1 MAP3K4 SYNGAP1 ARID1B UBR5 GLI3 PKD1 GTF2IRD2 NGFR PLAG1 STRA6 ADGRL2 METTL17 MED12 WNK2 EP400 MLLT10 RFX7 YEATS2 GTF2IRD2B TENM4 ARID2 SRRM2 SLC26A11 CRB2 | 2.17e-05 | 1245 | 192 | 27 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | MYLK USP9X BACE1 CLASP2 LRRTM3 RTN1 SLC12A5 ZNF462 GLI3 PLAG1 PUM2 MED1 HIPK3 TENM4 ASXL3 SIPA1L1 FOXP1 ASXL2 ZMYM4 EPHA7 | 5.50e-05 | 818 | 192 | 20 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_S-shaped body_emap-27855_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.46e-05 | 152 | 192 | 8 | gudmap_developingKidney_e15.5_S-shaped body_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | UBL7 SP1 ARID1A MAP3K4 KIDINS220 SGPL1 NFYA NGFR STRA6 BAG6 SMAP1 SH3RF1 PUM2 CHD8 SLC25A39 ASXL3 FOXP1 NFAT5 HCFC1 EPHA7 | 8.44e-05 | 844 | 192 | 20 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | BDP1 VPS13C TSC22D2 MAP3K4 ALMS1 UBR5 GLI3 FGF12 NIPBL CCDC40 POU2F1 STIL MLLT10 RFX7 PLK4 | 1.05e-04 | 532 | 192 | 15 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.11e-04 | 120 | 192 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | ZNF609 CHD3 ZNF462 ZFR2 LRRTM4 RHBDL3 FGF12 SETD4 CUTC SIPA1L1 TOX2 | 1.13e-04 | 306 | 192 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500 | 1.58e-04 | 89 | 192 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | ZFYVE16 USP9X ARID1A USP38 POU2F1 MED1 SBF2 ASXL2 ZNF281 ZMYM4 | 1.39e-08 | 193 | 194 | 10 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.85e-08 | 199 | 194 | 10 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.60e-07 | 190 | 194 | 9 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.75e-07 | 192 | 194 | 9 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.83e-07 | 193 | 194 | 9 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.83e-07 | 193 | 194 | 9 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.37e-07 | 199 | 194 | 9 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.37e-07 | 199 | 194 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.37e-07 | 199 | 194 | 9 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.37e-07 | 199 | 194 | 9 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.48e-07 | 200 | 194 | 9 | f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.64e-06 | 186 | 194 | 8 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.64e-06 | 186 | 194 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.78e-06 | 188 | 194 | 8 | 88b3415e33db81726dd29c1f50c886e057af50a0 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.78e-06 | 188 | 194 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.16e-06 | 193 | 194 | 8 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.16e-06 | 193 | 194 | 8 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.16e-06 | 193 | 194 | 8 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.51e-06 | 197 | 194 | 8 | 107cb153ea7fc74bbd244dbb9d0499c0a8506724 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.61e-06 | 198 | 194 | 8 | a8c21f4db6730d0aa05b61fbe72bf9f7571a9015 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.61e-06 | 198 | 194 | 8 | 8b68fc887e5ad0a59ea4d93dfd1edda67030f142 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.61e-06 | 198 | 194 | 8 | 4739b2e4ab141c66772e61686b45614a1839483e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.81e-06 | 200 | 194 | 8 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.63e-06 | 156 | 194 | 7 | 4877aabf647238c0279e497345b6a6d5ee07ef9c | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.63e-06 | 156 | 194 | 7 | 1d681fa17e62815f5d5f90c86be3c248b38e011b | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.21e-06 | 162 | 194 | 7 | fbb0cc2b1434a340dc35058b77c73ea61004c252 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.21e-06 | 162 | 194 | 7 | 45be019b50e3727fc9d3fad2ff78e74e4f2d746b | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 171 | 194 | 7 | 2e7cc311005958af52f39ca6c310c85b43a85aaf | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 171 | 194 | 7 | 4b599f953c8e5b947b2c8bbbf7fe6f9dc388e336 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-B_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 173 | 194 | 7 | 0a0cd40bb5f61431fe34758626c8a63ec610a8a5 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-05 | 173 | 194 | 7 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | Healthy_Control-Lymphoid-NK-CD8_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.15e-05 | 174 | 194 | 7 | 5dddb822fa51b4020e4d9318acacd19c726091d6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 177 | 194 | 7 | 73ba0f0b4b33f10e9f036d6d9befa48a1258e682 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-05 | 178 | 194 | 7 | 804ac3725c1f88e2212172bfb9aa01d97a735621 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-05 | 178 | 194 | 7 | ad6dc4a375664c919bd48c35c48a561fc5a7de8c | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-05 | 179 | 194 | 7 | 327cc39161741ddbc4e8d45b9b3d30b3ce508929 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-05 | 180 | 194 | 7 | f118c580134bdf3027e2218690cfc8a93468c1ae | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Mesenchymal-Mes|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-05 | 180 | 194 | 7 | 1ade66352570a3f869e21e1055d0a65fbf56c61d | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-05 | 183 | 194 | 7 | 310ad42b2b5d8ddd01d3a12db338f80ac1f5d08e | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-05 | 183 | 194 | 7 | 3ef9ac1ae13b6172f9121ab1c129ecaa0fef460f | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-05 | 183 | 194 | 7 | fef51dcf180e6d4e136362c7e140ec5ef372e6d0 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.77e-05 | 186 | 194 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 187 | 194 | 7 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 187 | 194 | 7 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.83e-05 | 187 | 194 | 7 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 1.89e-05 | 188 | 194 | 7 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-05 | 188 | 194 | 7 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.96e-05 | 189 | 194 | 7 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.03e-05 | 190 | 194 | 7 | da7341a8a423e5fe4d8e733d8e50c10a3318ac1c | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.03e-05 | 190 | 194 | 7 | 42312f7d79fe889397d32910b625793e2535cc26 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.03e-05 | 190 | 194 | 7 | 682418a7a2096743112eae3790d40e7e600612c0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.10e-05 | 191 | 194 | 7 | 5343a527de6b0f852f45020a91f5b4869e78f13a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.10e-05 | 191 | 194 | 7 | a25a5f9a380031fdaf57677a079f97a90f0550c0 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 192 | 194 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.24e-05 | 193 | 194 | 7 | 479abb1cd2eb978b8a4fdb900069a6329fc8cade | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-FDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.32e-05 | 194 | 194 | 7 | f9fbb043411546d8c9e0321a64165d411f44aeb7 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-J_(Lipofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.32e-05 | 194 | 194 | 7 | 784b15119c91ace33d34bfb3d68c182566a3e9a8 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.40e-05 | 195 | 194 | 7 | 1be9502577267ca2a04656a99d57e3e2f124d92e | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 2.40e-05 | 195 | 194 | 7 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | T_cells-GZMK+GZMB+_T_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.48e-05 | 196 | 194 | 7 | b237287def04def371191b054a41ec0b3150da75 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.56e-05 | 197 | 194 | 7 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.56e-05 | 197 | 194 | 7 | 76b61e60a757e58b465569538e632d6d9953e89a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.56e-05 | 197 | 194 | 7 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 2.56e-05 | 197 | 194 | 7 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.56e-05 | 197 | 194 | 7 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | Caecum-(6)_Macrophage-(61)_LYVE1_Macrophage|Caecum / shred on region, Cell_type, and subtype | 2.64e-05 | 198 | 194 | 7 | e684c3934c163aef4d284b69435832d2c9614f2a | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Caecum / Region, Cell class and subclass | 2.64e-05 | 198 | 194 | 7 | a92c0cacb775aca6bbb302bd9e22c081a112a44d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.64e-05 | 198 | 194 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.70e-05 | 134 | 194 | 6 | 9458e2d0dbc18d9025b66b59f3ecc2fbc5384940 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.70e-05 | 134 | 194 | 6 | a3547a68012d879d4dfe80394eace70808722e43 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-05 | 199 | 194 | 7 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 2.73e-05 | 199 | 194 | 7 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 2.73e-05 | 199 | 194 | 7 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 2.73e-05 | 199 | 194 | 7 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-05 | 199 | 194 | 7 | 6cfe5a3d0ad530411ebc11decb4ab4c529e018d5 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.82e-05 | 200 | 194 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.82e-05 | 200 | 194 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.82e-05 | 200 | 194 | 7 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-05 | 200 | 194 | 7 | 24e43d3d16d07571f77e0cd5b2e4758c6ff802cb | |
| ToppCell | distal-2-Endothelial-Capillary_Intermediate_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.82e-05 | 200 | 194 | 7 | 7a99f28670ffb8ece7873d8a9bcd2a3936d0255d | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.82e-05 | 200 | 194 | 7 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.90e-05 | 149 | 194 | 6 | a85a051e0d82430160967e72fa04b55f43e84513 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.08e-05 | 150 | 194 | 6 | 7a381f5ae94eba5eb60dcbf83416b4eb18c279ea | |
| ToppCell | Adult-Epithelial-basal_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.67e-05 | 153 | 194 | 6 | 9ee3e7f3f19a2474283c1c79045269686f35a541 | |
| ToppCell | Adult-Epithelial-basal_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.88e-05 | 154 | 194 | 6 | 38d346402417960044ae999e61f0092b46f2b591 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.32e-05 | 156 | 194 | 6 | 574f761962a7dd3308bd41fc529dd3ea1b8625f8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 6.32e-05 | 156 | 194 | 6 | 605d95a900e1443d3f6aae163ef2e893d3293203 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-C_(Capillary_Aerocyte_)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.55e-05 | 157 | 194 | 6 | 84f629b7f589ca8a1abc220fa740c4a6fdc1b579 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.53e-05 | 161 | 194 | 6 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Pre-B|bone_marrow / Manually curated celltypes from each tissue | 7.79e-05 | 162 | 194 | 6 | e088e66aabc307dde5d2b9aa295c34ef68155b1a | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.06e-05 | 163 | 194 | 6 | 3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.91e-05 | 166 | 194 | 6 | c215c4aede38d355d35fd26cd7ef2c19efecd0e6 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.21e-05 | 167 | 194 | 6 | 8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.83e-05 | 169 | 194 | 6 | 559e98216720e4babf0b0941100f1b485c35b11b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-04 | 170 | 194 | 6 | ce79f5d0d475fcb6c5a61c94938c65210b3c59d9 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-04 | 170 | 194 | 6 | 3ad9f950b87ee98f025ab9b4a8ed551e6a9b4764 | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 171 | 194 | 6 | 25493a4a7b636920e2cfd984542cc500709c9dcf | |
| ToppCell | droplet-Thymus-nan-3m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 171 | 194 | 6 | 508b41e3ad2638f9dd546d251b13ff60fc8c3207 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 172 | 194 | 6 | e15ab284df6dd241d4481f98864b18c39d757b8c | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.08e-04 | 172 | 194 | 6 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| Computational | Genes in the cancer module 277. | 4.24e-06 | 55 | 131 | 7 | MODULE_277 | |
| Drug | Potassium Chloride | 7.26e-08 | 6 | 192 | 4 | DB00761 | |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A | ZNF609 TSC22D2 NFYA NIPBL ADNP2 POU2F1 MED1 ZBTB11 NFAT5 ZNF281 HCFC1 | 2.80e-07 | 174 | 192 | 11 | 1302_UP |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | NCOA3 ZNF609 UBR5 GLI3 NIPBL POU2F1 EPN2 YEATS2 TENM4 SIPA1L1 | 2.00e-06 | 171 | 192 | 10 | 7535_DN |
| Drug | Apigenin [520-36-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A | CLASP2 ALMS1 GLI3 AGFG1 BAIAP2 NIPBL NUP98 SETD4 IVNS1ABP NFAT5 | 4.68e-06 | 188 | 192 | 10 | 3257_DN |
| Drug | Harmine hydrochloride [343-27-1]; Down 200; 16uM; PC3; HT_HG-U133A | CLASP2 ALMS1 NFYA BAIAP2 NIPBL MED8 NUP98 IVNS1ABP CUTC DIP2C | 5.14e-06 | 190 | 192 | 10 | 5855_DN |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | ASXL1 ZFYVE16 VPS13C CHD3 NEK9 ALMS1 UBR5 PTBP3 EP400 PIKFYVE | 5.39e-06 | 191 | 192 | 10 | 4168_DN |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | DYRK4 MAP3K4 NUP210 NIPBL IL27RA EP400 EPN2 YEATS2 HCFC1 ZMYM4 | 6.18e-06 | 194 | 192 | 10 | 1670_DN |
| Drug | Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 6.77e-06 | 196 | 192 | 10 | 1494_DN | |
| Drug | Practolol [6673-35-4]; Down 200; 15uM; HL60; HG-U133A | SRF CLASP2 DYRK4 NCAPD2 NFYA NIPBL EP400 SLC12A7 ZNF281 PLK4 | 7.08e-06 | 197 | 192 | 10 | 1587_DN |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 7.40e-06 | 198 | 192 | 10 | 1479_DN | |
| Drug | Oxaprozin [21256-18-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 7.74e-06 | 199 | 192 | 10 | 4352_DN | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 7.74e-06 | 199 | 192 | 10 | 1648_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.15e-05 | 165 | 192 | 9 | 6085_DN | |
| Drug | Antigens, Polyomavirus Transforming | NCOA3 SP1 ASXL1 ARID1A ARHGEF11 FMNL2 PHF2 KIDINS220 SIPA1L2 ZNF653 CNOT2 PTBP3 TCF20 DEPDC1 CSNK1G2 ARID2 PLK4 HCFC1 | 1.54e-05 | 668 | 192 | 18 | ctd:D000952 |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.21e-05 | 179 | 192 | 9 | 5822_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.21e-05 | 179 | 192 | 9 | 4483_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 2.31e-05 | 180 | 192 | 9 | 4541_DN | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; PC3; HT_HG-U133A | 2.41e-05 | 181 | 192 | 9 | 1791_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 2.52e-05 | 182 | 192 | 9 | 1891_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 2.52e-05 | 182 | 192 | 9 | 1951_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.52e-05 | 182 | 192 | 9 | 5802_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.75e-05 | 184 | 192 | 9 | 2321_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.12e-05 | 187 | 192 | 9 | 6671_DN | |
| Drug | Oleandomycin phosphate [7060-74-4]; Up 200; 5uM; PC3; HG-U133A | NCOA3 ARHGEF11 TSC22D1 GLI3 METTL17 POU2F1 MED1 IVNS1ABP CSNK1G2 | 4.16e-05 | 194 | 192 | 9 | 1935_UP |
| Drug | Nifedipine [21829-25-4]; Down 200; 11.6uM; HL60; HT_HG-U133A | 4.16e-05 | 194 | 192 | 9 | 1856_DN | |
| Drug | NS-398; Up 200; 10uM; MCF7; HT_HG-U133A | 4.16e-05 | 194 | 192 | 9 | 6897_UP | |
| Drug | NSC618487 | MYLK MAML1 NEK9 MAP3K4 NGFR SLA2 PARP9 ALOX15B SLC12A6 ANK1 CDKL2 FPR1 PIKFYVE PARP10 SLC12A4 CSNK1G2 GYS2 TNS4 SLC12A7 PLK4 EPHA7 | 4.31e-05 | 933 | 192 | 21 | CID000005279 |
| Drug | Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; MCF7; HT_HG-U133A | 4.33e-05 | 195 | 192 | 9 | 6234_DN | |
| Drug | Hesperetin [520-33-2]; Down 200; 13.2uM; HL60; HG-U133A | 4.51e-05 | 196 | 192 | 9 | 2031_DN | |
| Drug | (-)-depudecin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 4.51e-05 | 196 | 192 | 9 | 874_DN | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 4.51e-05 | 196 | 192 | 9 | 1662_DN | |
| Drug | Piperacetazine [3819-00-9]; Down 200; 9.8uM; PC3; HT_HG-U133A | 4.69e-05 | 197 | 192 | 9 | 5834_DN | |
| Drug | SB 203580; Down 200; 1uM; MCF7; HT_HG-U133A | 4.69e-05 | 197 | 192 | 9 | 7061_DN | |
| Drug | Boldine [476-70-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 4.69e-05 | 197 | 192 | 9 | 2804_DN | |
| Drug | LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A | ZNF609 ARHGEF11 CASZ1 SLC12A5 ALMS1 NUP210 FGF12 TAF4B MED12 | 4.88e-05 | 198 | 192 | 9 | 6976_UP |
| Drug | Fluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 4.88e-05 | 198 | 192 | 9 | 6083_DN | |
| Drug | Morantel tartrate [26155-31-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 4.88e-05 | 198 | 192 | 9 | 7010_DN | |
| Drug | Dienestrol [84-17-3]; Down 200; 15uM; MCF7; HT_HG-U133A | 4.88e-05 | 198 | 192 | 9 | 6208_DN | |
| Drug | Hemicholinium bromide [312-45-8]; Up 200; 7uM; MCF7; HT_HG-U133A | 5.07e-05 | 199 | 192 | 9 | 3216_UP | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HG-U133A | 5.07e-05 | 199 | 192 | 9 | 122_DN | |
| Drug | Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; PC3; HT_HG-U133A | 5.27e-05 | 200 | 192 | 9 | 7129_DN | |
| Drug | Lidoflazine [3416-26-0]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 5.27e-05 | 200 | 192 | 9 | 6278_DN | |
| Drug | ((2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy)acetic acid | 7.07e-05 | 2 | 192 | 2 | ctd:C095651 | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Up 200; 5.6uM; HL60; HG-U133A | 8.93e-05 | 167 | 192 | 8 | 1745_UP | |
| Drug | DCPIB | 9.27e-05 | 11 | 192 | 3 | CID010071166 | |
| Drug | Vanadates | EPS8 USP9X BACE1 SYNC ITGB3 TSC22D1 GLI3 NUP210 NAV1 TAF4B SIPA1L2 ADGRL2 DEPDC1 MED1 EPN2 CUTC SLC12A4 RALGPS1 SIPA1L1 RAVER2 DIP2C FHDC1 CDC25A SLC12A7 TOX2 | 1.04e-04 | 1302 | 192 | 25 | ctd:D014638 |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.10e-04 | 172 | 192 | 8 | 7073_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 1.19e-04 | 174 | 192 | 8 | 7530_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.24e-04 | 175 | 192 | 8 | 3787_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.24e-04 | 175 | 192 | 8 | 4072_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.29e-04 | 176 | 192 | 8 | 6784_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.29e-04 | 176 | 192 | 8 | 3312_DN | |
| Drug | Mercury | NCOA3 ATP7B SRF CLASP2 ARID1A NGFR BAG6 FOXK1 ANK1 CDKL2 LEPR IVNS1ABP PIKFYVE SLC22A4 RACGAP1 | 1.37e-04 | 584 | 192 | 15 | ctd:D008628 |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.39e-04 | 178 | 192 | 8 | 4436_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.56e-04 | 181 | 192 | 8 | 3643_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.62e-04 | 182 | 192 | 8 | 3887_DN | |
| Drug | Rifabutin [72559-06-9]; Down 200; 4.8uM; PC3; HT_HG-U133A | 1.68e-04 | 183 | 192 | 8 | 4527_DN | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 1.81e-04 | 185 | 192 | 8 | 1114_DN | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 2.02e-04 | 188 | 192 | 8 | 4845_DN | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.10e-04 | 189 | 192 | 8 | 1065_DN | |
| Drug | thiocholesterol | 2.11e-04 | 3 | 192 | 2 | CID000065075 | |
| Drug | Deptropine citrate [2169-75-7]; Down 200; 7.6uM; HL60; HT_HG-U133A | 2.17e-04 | 190 | 192 | 8 | 3144_DN | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 2.25e-04 | 191 | 192 | 8 | 6987_DN | |
| Drug | daunorubicin HCl; Down 200; 1uM; MCF7; HT_HG-U133A | 2.25e-04 | 191 | 192 | 8 | 7507_DN | |
| Drug | 5114445; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.42e-04 | 193 | 192 | 8 | 901_DN | |
| Drug | radicicol; Up 200; 0.1uM; HL60; HG-U133A | 2.42e-04 | 193 | 192 | 8 | 544_UP | |
| Drug | phenanthridinone; Down 200; 51.2uM; MCF7; HT_HG-U133A_EA | 2.50e-04 | 194 | 192 | 8 | 1115_DN | |
| Drug | Piroxicam [36322-90-4]; Down 200; 12uM; HL60; HG-U133A | 2.50e-04 | 194 | 192 | 8 | 1405_DN | |
| Drug | Dirithromycin [62013-04-1]; Down 200; 4.8uM; HL60; HG-U133A | 2.50e-04 | 194 | 192 | 8 | 1712_DN | |
| Drug | Laudanosine (R,S) [1699-51-0]; Down 200; 11.2uM; HL60; HG-U133A | 2.50e-04 | 194 | 192 | 8 | 1741_DN | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | 2.59e-04 | 195 | 192 | 8 | 7444_DN | |
| Drug | semustine; Down 200; 100uM; MCF7; HT_HG-U133A | 2.59e-04 | 195 | 192 | 8 | 7540_DN | |
| Drug | Nadide [53-84-9]; Up 200; 6uM; HL60; HT_HG-U133A | 2.59e-04 | 195 | 192 | 8 | 2529_UP | |
| Drug | Vidarabine [5536-17-4]; Down 200; 15uM; PC3; HT_HG-U133A | 2.59e-04 | 195 | 192 | 8 | 5850_DN | |
| Drug | (R)-Propranolol hydrochloride [13071-11-9]; Down 200; 13.6uM; PC3; HT_HG-U133A | 2.59e-04 | 195 | 192 | 8 | 5814_DN | |
| Drug | Edrophonium chloride [116-38-1]; Down 200; 19.8uM; HL60; HG-U133A | 2.68e-04 | 196 | 192 | 8 | 2019_DN | |
| Drug | Midodrine hydrochloride [3092-17-9]; Down 200; 13.8uM; HL60; HG-U133A | 2.68e-04 | 196 | 192 | 8 | 1403_DN | |
| Drug | SR-95639A [115767-94-7]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.68e-04 | 196 | 192 | 8 | 3272_DN | |
| Drug | Ethoxyquin [91-53-2]; Up 200; 18.4uM; PC3; HT_HG-U133A | 2.68e-04 | 196 | 192 | 8 | 4321_UP | |
| Drug | N-Acetyl-L-leucine [1188-21-2]; Down 200; 23uM; MCF7; HT_HG-U133A | 2.68e-04 | 196 | 192 | 8 | 6462_DN | |
| Drug | Ivermectin [70288-86-7]; Down 200; 4.6uM; HL60; HG-U133A | 2.68e-04 | 196 | 192 | 8 | 1367_DN | |
| Drug | felodipine; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.68e-04 | 196 | 192 | 8 | 848_DN | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 2.68e-04 | 196 | 192 | 8 | 3256_UP | |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; PC3; HT_HG-U133A | 2.68e-04 | 196 | 192 | 8 | 5052_UP | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 2.77e-04 | 197 | 192 | 8 | 1071_UP | |
| Drug | Clozapine [5786-21-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 2.77e-04 | 197 | 192 | 8 | 2644_DN | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 2.77e-04 | 197 | 192 | 8 | 5340_DN | |
| Drug | Tolnaftate [2398-96-1]; Up 200; 13uM; PC3; HG-U133A | 2.77e-04 | 197 | 192 | 8 | 1919_UP | |
| Drug | Methiazole; Down 200; 15uM; MCF7; HT_HG-U133A | 2.77e-04 | 197 | 192 | 8 | 4354_DN | |
| Drug | Mafenide hydrochloride [138-37-4]; Down 200; 18uM; PC3; HT_HG-U133A | 2.77e-04 | 197 | 192 | 8 | 2124_DN | |
| Drug | Idoxuridine [54-42-2]; Down 200; 11.2uM; PC3; HG-U133A | 2.77e-04 | 197 | 192 | 8 | 1899_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; PC3; HT_HG-U133A | 2.77e-04 | 197 | 192 | 8 | 1240_DN | |
| Drug | Reserpine [50-55-5]; Down 200; 6.6uM; HL60; HT_HG-U133A | 2.87e-04 | 198 | 192 | 8 | 3003_DN | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; HL60; HG-U133A | 2.87e-04 | 198 | 192 | 8 | 1997_DN | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; PC3; HG-U133A | 2.87e-04 | 198 | 192 | 8 | 1900_DN | |
| Drug | Metolazone [17560-51-9]; Down 200; 11uM; PC3; HT_HG-U133A | 2.87e-04 | 198 | 192 | 8 | 6292_DN | |
| Drug | Racecadotril [81110-73-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 2.87e-04 | 198 | 192 | 8 | 2774_DN | |
| Drug | Isocarboxazid [59-63-2]; Down 200; 17.2uM; MCF7; HT_HG-U133A | 2.87e-04 | 198 | 192 | 8 | 3424_DN | |
| Drug | BAS 012416453; Down 200; 38uM; MCF7; HT_HG-U133A | 2.87e-04 | 198 | 192 | 8 | 6880_DN | |
| Drug | S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.87e-04 | 198 | 192 | 8 | 3393_UP | |
| Disease | alcohol use disorder (implicated_via_orthology) | 5.71e-06 | 195 | 192 | 9 | DOID:1574 (implicated_via_orthology) | |
| Disease | Sezary Syndrome | 2.71e-05 | 27 | 192 | 4 | C0036920 | |
| Disease | Neurodevelopmental Disorders | 3.34e-05 | 93 | 192 | 6 | C1535926 | |
| Disease | Bilateral Wilms Tumor | 3.63e-05 | 29 | 192 | 4 | C2930471 | |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 4.21e-05 | 2 | 192 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | NCOA3 ATP7B CHD3 ARID1A ITGB3 CASZ1 KMT2C NGFR MED12 IVNS1ABP KMT2D ARID2 INTS4 CD276 | 5.61e-05 | 616 | 192 | 14 | C0033578 |
| Disease | Malignant neoplasm of prostate | NCOA3 ATP7B CHD3 ARID1A ITGB3 CASZ1 KMT2C NGFR MED12 IVNS1ABP KMT2D ARID2 INTS4 CD276 | 5.61e-05 | 616 | 192 | 14 | C0376358 |
| Disease | Coffin-Siris syndrome | 7.39e-05 | 13 | 192 | 3 | C0265338 | |
| Disease | Nephroblastoma | 8.70e-05 | 36 | 192 | 4 | C0027708 | |
| Disease | Liver carcinoma | ARID1A KMT2C ARID1B VCAM1 NOTCH3 DEPDC1 LCAT MED1 ARID2 GYS2 RACGAP1 CD276 | 1.32e-04 | 507 | 192 | 12 | C2239176 |
| Disease | T-Cell Lymphoma | 1.43e-04 | 16 | 192 | 3 | C0079772 | |
| Disease | brain connectivity measurement | ADAM15 TSC22D2 GLI3 WNK2 TBX15 STIL MLLT10 TENM4 FOXP1 EPHA7 | 3.12e-04 | 400 | 192 | 10 | EFO_0005210 |
| Disease | Bladder Neoplasm | 3.20e-04 | 140 | 192 | 6 | C0005695 | |
| Disease | diaphragmatic hernia | 3.31e-04 | 21 | 192 | 3 | EFO_0008561 | |
| Disease | Malignant neoplasm of urinary bladder | 3.32e-04 | 141 | 192 | 6 | C0005684 | |
| Disease | disease recurrence, colon carcinoma | 3.42e-04 | 51 | 192 | 4 | EFO_0004952, EFO_1001950 | |
| Disease | response to tenofovir | 3.42e-04 | 51 | 192 | 4 | EFO_0009279 | |
| Disease | IGF-1 measurement | VPS13C ARID1A ZNF462 PHF2 BAIAP2 MED8 NUP98 SETD4 LEPR ASXL2 PLK4 | 3.79e-04 | 488 | 192 | 11 | EFO_0004627 |
| Disease | Malignant Cystosarcoma Phyllodes | 4.16e-04 | 5 | 192 | 2 | C0600066 | |
| Disease | Phyllodes Tumor | 4.16e-04 | 5 | 192 | 2 | C0010701 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 4.16e-04 | 5 | 192 | 2 | C3281201 | |
| Disease | Klatskin's tumor (is_implicated_in) | 4.16e-04 | 5 | 192 | 2 | DOID:4927 (is_implicated_in) | |
| Disease | obesity (implicated_via_orthology) | 5.42e-04 | 215 | 192 | 7 | DOID:9970 (implicated_via_orthology) | |
| Disease | laryngeal carcinoma (is_marker_for) | 6.21e-04 | 6 | 192 | 2 | DOID:2600 (is_marker_for) | |
| Disease | serum IgG glycosylation measurement | VPS13C TSC22D2 FMNL2 ITGB3 EFEMP1 GLI3 LRRTM4 CCDC40 DEPDC1 FRY FOXP1 | 6.73e-04 | 523 | 192 | 11 | EFO_0005193 |
| Disease | red blood cell density measurement | SP1 ARHGEF11 HNF4A CASZ1 ZNF462 ARID1B UBR5 TAF4B ANK1 EP400 RFX7 SLC34A1 ARID2 SBF2 FOXP1 | 6.82e-04 | 880 | 192 | 15 | EFO_0007978 |
| Disease | insomnia measurement | 6.89e-04 | 443 | 192 | 10 | EFO_0007876 | |
| Disease | Malignant neoplasm of breast | NCOA3 ATP7B ARID1A ARID1B EFEMP1 NIPBL MED12 NOTCH3 ANK1 NUP98 POU2F1 LEPR CUTC KMT2D SIPA1L1 DIP2C ZNF281 | 6.92e-04 | 1074 | 192 | 17 | C0006142 |
| Disease | Bone Diseases, Developmental | 7.07e-04 | 27 | 192 | 3 | C0005941 | |
| Disease | Colorectal Carcinoma | ATP7B ARID1A SLC12A5 KMT2C EFEMP1 GLI3 TFEC SETD4 DMKN DIP2C TNS4 ZMYM4 EPHA7 | 7.33e-04 | 702 | 192 | 13 | C0009402 |
| Disease | hair colour measurement | ASXL1 ZFYVE16 ARID1A ITGB3 SLA2 SIPA1L2 PUM2 KMT2D TENM4 RALGPS1 SBF2 ASXL2 | 7.46e-04 | 615 | 192 | 12 | EFO_0007822 |
| Disease | fibrinogen measurement | 7.48e-04 | 109 | 192 | 5 | EFO_0004623 | |
| Disease | Lymphopenia | 8.66e-04 | 7 | 192 | 2 | C0024312 | |
| Disease | breast carcinoma (is_marker_for) | 9.14e-04 | 66 | 192 | 4 | DOID:3459 (is_marker_for) | |
| Disease | susceptibility to childhood ear infection measurement | 9.18e-04 | 171 | 192 | 6 | EFO_0007904 | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.08e-03 | 69 | 192 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | chin morphology measurement | 1.14e-03 | 70 | 192 | 4 | EFO_0007842 | |
| Disease | Mental Retardation, X-Linked 1 | 1.17e-03 | 32 | 192 | 3 | C2931498 | |
| Disease | lymphocyte count | ARHGEF11 FMNL2 CASZ1 GGT5 ALMS1 SGPL1 GTF2IRD2 PLAG1 VCAM1 IL27RA MIER2 ANK1 FPR1 RFX7 LEPR GTF2IRD2B TENM4 SLC22A4 FOXP1 MUC22 | 1.45e-03 | 1464 | 192 | 20 | EFO_0004587 |
| Disease | neuroblastoma (is_implicated_in) | 1.83e-03 | 10 | 192 | 2 | DOID:769 (is_implicated_in) | |
| Disease | Epilepsy, Cryptogenic | 2.05e-03 | 82 | 192 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 2.05e-03 | 82 | 192 | 4 | C0751111 | |
| Disease | Aura | 2.05e-03 | 82 | 192 | 4 | C0236018 | |
| Disease | Hypercholesterolemia | 2.09e-03 | 39 | 192 | 3 | C0020443 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.20e-03 | 139 | 192 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | Microphthalmos | 2.23e-03 | 11 | 192 | 2 | C0026010 | |
| Disease | Macrocephaly | 2.23e-03 | 11 | 192 | 2 | C0221355 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 2.23e-03 | 11 | 192 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to methazolamide | 2.23e-03 | 11 | 192 | 2 | EFO_0004276, EFO_0004775, EFO_0020996 | |
| Disease | insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation | 2.23e-03 | 11 | 192 | 2 | EFO_0004471, EFO_0009131 | |
| Disease | interleukin-6 measurement, response to stimulus | 2.23e-03 | 11 | 192 | 2 | EFO_0004810, GO_0050896 | |
| Disease | Moyamoya disease | 2.24e-03 | 40 | 192 | 3 | MONDO_0016820 | |
| Disease | uric acid measurement | ARID1A HNF4A NAV1 ADGRL2 FOXK1 CDC42BPG SBF2 SLC22A4 DIP2C ASXL2 NFAT5 | 2.29e-03 | 610 | 192 | 11 | EFO_0004761 |
| Disease | Autism Spectrum Disorders | 2.33e-03 | 85 | 192 | 4 | C1510586 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | ARPP21 ADAM15 ARID1B ALMS1 LRRTM4 BAIAP2 SIPA1L2 ADGRL2 TCF20 TENM4 FOXP1 NFAT5 CD276 | 2.37e-03 | 801 | 192 | 13 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | mean corpuscular hemoglobin concentration | SP1 ATP7B BRDT UBR5 PARP9 CCDC40 ANK1 EP400 INTS8 LEPR SLC34A1 FOXP1 ASXL2 SLC12A7 TOX2 PLK4 | 2.45e-03 | 1105 | 192 | 16 | EFO_0004528 |
| Disease | bilirubin measurement | 2.55e-03 | 442 | 192 | 9 | EFO_0004570 | |
| Disease | Charcot-Marie-Tooth disease | 2.58e-03 | 42 | 192 | 3 | cv:C0007959 | |
| Disease | sialic acid-binding Ig-like lectin 14 measurement | 2.66e-03 | 12 | 192 | 2 | EFO_0008284 | |
| Disease | Gastrointestinal Diseases | 2.66e-03 | 12 | 192 | 2 | C0017178 | |
| Disease | Functional Gastrointestinal Disorders | 2.66e-03 | 12 | 192 | 2 | C0559031 | |
| Disease | Cholera Infantum | 2.66e-03 | 12 | 192 | 2 | C1565321 | |
| Disease | intracranial aneurysm (is_implicated_in) | 2.66e-03 | 12 | 192 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | Intellectual Disability | 2.75e-03 | 447 | 192 | 9 | C3714756 | |
| Disease | serum gamma-glutamyl transferase measurement | ARPP21 ADAM15 ARID1A ARHGEF11 HNF4A EXOC3L4 PKD1 SIPA1L2 ADGRL2 FPR1 TENM4 GYS2 SPATA13 CD276 | 2.75e-03 | 914 | 192 | 14 | EFO_0004532 |
| Disease | neutrophil count, eosinophil count | 2.79e-03 | 213 | 192 | 6 | EFO_0004833, EFO_0004842 | |
| Disease | vital capacity | NCOA3 CASZ1 EFEMP1 GLI3 LRRTM4 PLAG1 PARP9 ADGRL2 FOXK1 TBX15 TCF20 MLLT10 MED1 LEPR SLC34A1 FOXP1 NFAT5 | 3.06e-03 | 1236 | 192 | 17 | EFO_0004312 |
| Disease | Charcot-Marie-Tooth disease type 4 | 3.13e-03 | 13 | 192 | 2 | cv:C4082197 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.24e-03 | 152 | 192 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | neutrophil count, basophil count | 3.57e-03 | 224 | 192 | 6 | EFO_0004833, EFO_0005090 | |
| Disease | Adenocarcinoma Of Esophagus | 3.64e-03 | 14 | 192 | 2 | C0279628 | |
| Disease | Hiatus hernia | 3.64e-03 | 14 | 192 | 2 | HP_0002036 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 3.72e-03 | 157 | 192 | 5 | DOID:224 (biomarker_via_orthology) | |
| Disease | phospholipids:total lipids ratio | 3.81e-03 | 227 | 192 | 6 | EFO_0020946 | |
| Disease | neutrophil count | SP1 MAML1 ARID1A HNF4A CASZ1 KIDINS220 PKD1 ADGRL2 TBX15 POU2F1 LEPR SBF2 SLC22A4 FOXP1 MUC22 SLC12A7 TOX2 ZMYM4 | 4.12e-03 | 1382 | 192 | 18 | EFO_0004833 |
| Disease | neuroticism measurement, cognitive function measurement | ASXL1 TSC22D2 ARID1A SYNGAP1 NAV1 BAIAP2 MLLT10 ASXL3 SIPA1L1 FOXP1 | 4.13e-03 | 566 | 192 | 10 | EFO_0007660, EFO_0008354 |
| Disease | N-acetylmethionine measurement | 4.18e-03 | 15 | 192 | 2 | EFO_0021427 | |
| Disease | Tourette syndrome | 4.25e-03 | 50 | 192 | 3 | EFO_0004895 | |
| Disease | neurotic disorder | 4.34e-03 | 101 | 192 | 4 | EFO_0004257 | |
| Disease | pancreatic cancer (is_marker_for) | 4.34e-03 | 101 | 192 | 4 | DOID:1793 (is_marker_for) | |
| Disease | epilepsy (implicated_via_orthology) | 4.36e-03 | 163 | 192 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | lymphocyte percentage of leukocytes | ARID1A HNF4A UBR5 GTF2IRD2 VCAM1 IL27RA ANK1 RFX7 LEPR GTF2IRD2B FOXP1 | 4.38e-03 | 665 | 192 | 11 | EFO_0007993 |
| Disease | diastolic blood pressure, systolic blood pressure | SP1 ADAM15 MAML1 CASZ1 ARID1B EFEMP1 ALMS1 NAV1 TBX15 TENM4 NFAT5 | 4.63e-03 | 670 | 192 | 11 | EFO_0006335, EFO_0006336 |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 4.76e-03 | 16 | 192 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | lipoprotein measurement | 4.98e-03 | 105 | 192 | 4 | EFO_0004732 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 5.00e-03 | 53 | 192 | 3 | C4707243 | |
| Disease | Astrocytosis | 5.37e-03 | 17 | 192 | 2 | C3887640 | |
| Disease | Gliosis | 5.37e-03 | 17 | 192 | 2 | C0017639 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 5.37e-03 | 17 | 192 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | Ischemic stroke, fibrinogen measurement | 5.55e-03 | 55 | 192 | 3 | EFO_0004623, HP_0002140 | |
| Disease | Epilepsy | 5.68e-03 | 109 | 192 | 4 | C0014544 | |
| Disease | creatinine measurement | ARID1A HNF4A CASZ1 ALMS1 ADGRL2 MED1 INTS8 CUTC FRY SLC34A1 SLC22A4 DIP2C ASXL2 NFAT5 | 5.78e-03 | 995 | 192 | 14 | EFO_0004518 |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 5.84e-03 | 56 | 192 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | free cholesterol in medium HDL measurement | 6.44e-03 | 58 | 192 | 3 | EFO_0022267 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TSVQPGSSGMASVIV | 496 | P59817 | |
| GSSGMASVIVSNTDP | 501 | P59817 | |
| VPSGVMNGVSQQAST | 106 | Q17RC7 | |
| TGTSMPTGAVSGNVI | 2621 | Q96L91 | |
| PLNQSEVLASVGGSM | 221 | P56817 | |
| PATSVGQDAMGLSIS | 2336 | A6H8Y1 | |
| QGNPFMGVSATAVSS | 131 | Q9HCK8 | |
| PIQINVGTTVTMTGN | 376 | P46379 | |
| PSGDSEQLSNGITVM | 761 | Q58F21 | |
| GNESTAAGNTISMPT | 1381 | Q86V15 | |
| GTSFSGPTVGMAIQN | 306 | Q13444 | |
| AGNSMVQTTDGTPTS | 441 | P35670 | |
| TPTAVMVGTGVAAQN | 991 | P35670 | |
| SFQGTSTMTEGLEPG | 1731 | P16157 | |
| VMGIPSVTTNLSGFG | 521 | P54840 | |
| VSAAPGLADQTTGMS | 601 | Q8TCU4 | |
| IGVSTSGSQGIIEPM | 776 | Q96L96 | |
| MQGEKGTQSEGSAPT | 906 | Q96L96 | |
| GTQSEGSAPTAMEGQ | 911 | Q96L96 | |
| GSSPSSMGISGLQQD | 121 | O15085 | |
| NATQLIAPAGITMSG | 1191 | Q68CP9 | |
| IAPAGITMSGTQTGV | 1196 | Q68CP9 | |
| ITMSGTQTGVGLPVQ | 1201 | Q68CP9 | |
| QKGPMSTTVAGSQEG | 426 | O95490 | |
| PSVMGLAAGVSGTSQ | 661 | Q5JTC6 | |
| GPQTPQSTGSNSMAE | 1261 | Q8NFD5 | |
| QSTGSNSMAEVPGDL | 1266 | Q8NFD5 | |
| GQGVPLTGNVTTSQM | 181 | Q5ZPR3 | |
| GVPLTGNVTTSQMAN | 401 | Q5ZPR3 | |
| GMESTGVSATGVENP | 681 | Q8TF21 | |
| FGQMTLSRQSSGETP | 556 | Q9UBL0 | |
| STNSMSGGVQTPRED | 1341 | Q8IXJ9 | |
| PGSQVSSNVGDVMSF | 1346 | Q76L83 | |
| IPGSEEQATVSMGTT | 1376 | Q9C0F0 | |
| ATSGVLPTGQMVQSG | 471 | Q6IQ32 | |
| QPATVGMAEGNFSGS | 511 | Q9HCJ3 | |
| GLMASVLVTSATPQG | 6 | Q5JS13 | |
| GGEMSPQVETSIEGT | 931 | Q96HW7 | |
| EPGMVNGETESSTAG | 226 | Q75QN2 | |
| GNQVPMDSSGATVGL | 241 | Q8TB72 | |
| GSATGDVQPTMNAIA | 516 | Q15397 | |
| NITSISFPALGTGNM | 421 | Q8IXQ6 | |
| NTNGMVDSSVAVGTP | 221 | Q6DT37 | |
| AGSGSMQGPQTPQST | 1136 | O14497 | |
| MELPQGQTGSVGTSV | 166 | Q7LBR1 | |
| QSGSLSPVSGSMQET | 1471 | Q8N7Z5 | |
| LIGATMQVTSEGGPQ | 1091 | Q8TEM1 | |
| GVGEMGDSQVSSNPT | 811 | Q9C0D6 | |
| SAQGTVIGSSPQMSG | 531 | P51610 | |
| TIPMSAIITQAGATG | 771 | P51610 | |
| GQFTGSSAAVPGMNT | 686 | Q92585 | |
| ILTTETTNGPGSMAV | 1021 | Q8WXI7 | |
| TTNGPGSMAVASTNI | 1026 | Q8WXI7 | |
| STEMAITNQTGPIGT | 5856 | Q8WXI7 | |
| STIGQPSTNTMGLFG | 306 | P52948 | |
| PSTNTMGLFGVTQAS | 311 | P52948 | |
| IPMAGDTQGVVGTVS | 276 | Q460N3 | |
| IAQMSQLEGGPGSTT | 1391 | Q9ULH0 | |
| DGSQVTMTVQVSGNP | 636 | Q15746 | |
| GTQSNNTCSLGGPMT | 811 | P10071 | |
| QTSQSGTSSMSGPQQ | 3016 | Q8NEZ4 | |
| STNTVGLGLPMSRSQ | 446 | Q14677 | |
| TNSETMDISVNGSGP | 491 | Q86VH4 | |
| LISPTEAMGNSNGAS | 791 | Q8TD19 | |
| PATSEGQVTISTMTG | 316 | O60721 | |
| GQVTISTMTGSSPAE | 321 | O60721 | |
| SFSMGNIPVATLSQG | 416 | Q9Y692 | |
| NMTSPRSNAGIATVG | 591 | Q9Y6Y0 | |
| SGSPEGAGMTTVQTI | 116 | Q8N307 | |
| GAGMTTVQTITGSDP | 121 | Q8N307 | |
| SSTFQETGPVSMGTN | 1626 | E2RYF6 | |
| MGEEQNSSISPSNGV | 1711 | Q86WG5 | |
| GQNTTFSVMAGSPIQ | 436 | Q5IJ48 | |
| MGSNQITFGRGSSQP | 161 | O95208 | |
| RTPVNITMAGDSGNG | 31 | A1A4Y4 | |
| ILSSGNGTAINMTPA | 1481 | Q5HYC2 | |
| NGTAINMTPALTSTG | 1486 | Q5HYC2 | |
| RSSGTSSGVLMVGPN | 31 | P78368 | |
| VQVLTMGNDTSPSEG | 31 | P41235 | |
| VPIISTSGNAGMTGV | 1706 | Q7Z5P9 | |
| TSGNAGMTGVVSPTV | 1711 | Q7Z5P9 | |
| TTASMGNPTLGNLAS | 586 | Q9H334 | |
| MQQASVSSPIVAGGL | 201 | Q6KC79 | |
| QETGSTGNGSRPALM | 526 | Q6KC79 | |
| ATGAMATTTGALPAQ | 2276 | Q9UM47 | |
| PNVGQGSTSVQTAME | 536 | Q5TB30 | |
| AQSGTSPSVCMNVSG | 456 | Q6UWB1 | |
| TSGGVIFQSPLMSVQ | 216 | P48357 | |
| QGVSQTLRAMAGGPT | 346 | Q969G2 | |
| TPMSAQGVQAGVRST | 2031 | Q93074 | |
| FSGGQLMVTGPVATA | 141 | O14520 | |
| ITTGQAAPSQVSGVM | 436 | Q15375 | |
| TNMGNPVTVVTATTG | 156 | Q9H422 | |
| QIQSGVSPGMFSSTE | 836 | O94916 | |
| NLSSVGSLMNGPSFT | 691 | A8MWY0 | |
| PLGTSQVMVTASGLQ | 556 | P14859 | |
| PIIMGSNIGTSVTNT | 186 | Q06495 | |
| AVAPSINSGMGTETI | 421 | Q92772 | |
| MSGGQTNRTTETEPQ | 1721 | Q9Y2I7 | |
| AAVGAEVSMTSPGQS | 491 | Q9NR20 | |
| GGSTPVSSANVMSGI | 341 | Q8NEV1 | |
| QSQGSIGETTPAAGM | 356 | Q8WWV6 | |
| GESGIQNSETSPGMF | 341 | Q6E0U4 | |
| SQMPAGSFITAATNG | 1951 | Q12873 | |
| METGQQPSGLSATLT | 41 | Q7Z4B0 | |
| QMGQVTSGPAVGRLT | 171 | Q4G0X9 | |
| GVSVSEMEATGAQGP | 341 | Q96BT3 | |
| DSQGTPTSSQGSINM | 146 | Q9Y2E4 | |
| AGGVIQTVASQMAPG | 581 | P85037 | |
| VCTSVVNPQSMGLGG | 76 | P36269 | |
| SEVVAGNSVGPTMGA | 506 | Q96PY5 | |
| SEGGTTPSMGVLQVV | 56 | Q9NTM9 | |
| IPGTTVGVLSMDSSN | 351 | P05106 | |
| VLASGDNQGIPIMSS | 246 | P04180 | |
| NMVVQATGGPELASS | 366 | Q12929 | |
| GGSSGNLPQMTQEVE | 1766 | Q5TBA9 | |
| TGQLNMNPGTTSGNT | 1956 | Q5TBA9 | |
| MNPGTTSGNTATAER | 1961 | Q5TBA9 | |
| VASTGTPAMVDANNG | 616 | Q86UP8 | |
| VASTGTPAMVDANNG | 616 | Q6EKJ0 | |
| ISMSAIATNGVVPAG | 236 | Q9UHW9 | |
| MSAIATNGVVPAGGS | 171 | Q9Y666 | |
| SASIIPNGFNGMSVV | 26 | Q9H015 | |
| PQTLMDFGSGTGSVT | 186 | Q9H7H0 | |
| TTGNNPMSGTTTPTN | 551 | Q15648 | |
| EPGLQTTAVVSMGSG | 26 | Q8N344 | |
| AGGLSPVTNLTVTMD | 36 | P30304 | |
| MTAGNPLGSANATVE | 1781 | P98161 | |
| RTGPMGSLGQAEQVS | 336 | Q53GL7 | |
| ISMSAIATNGVVPAG | 171 | Q9H2X9 | |
| GGQLITSTGQPIMVQ | 66 | P23511 | |
| GTSGLQQVQMAGAPS | 216 | Q96G25 | |
| SVQSSTRNAGPAMAG | 726 | A6ND36 | |
| NAQTMPGEVNSTLGT | 1491 | Q9Y6R4 | |
| AMVASVLGPGTSLQA | 266 | O15296 | |
| TAVVSAQPEGMASNG | 41 | Q5VT03 | |
| PPATGTATVMQTGGS | 611 | Q8NEY1 | |
| VVAASSMATSGVLPG | 101 | Q12805 | |
| SSGTPTMNGGKVVNQ | 226 | P61328 | |
| SPVAMETASTGVAGV | 71 | Q16799 | |
| AVSASGTVTMAPAGA | 16 | Q92750 | |
| APTSQAGGMETQSQG | 466 | Q9H7C4 | |
| MTATTRGSPVGGNDN | 1 | Q93008 | |
| NPSTKLQEGGSVTMT | 231 | P19320 | |
| MTGGLSVKDPSQSQS | 1281 | Q9HCJ0 | |
| SSRTPMSVLQQAGGS | 2141 | Q9UQ35 | |
| TFTGAQAGRTSQPMA | 1031 | O75151 | |
| LSSSVQGQGPVTMEA | 16 | Q9H6Q3 | |
| SVGAQLMGASSQPSE | 421 | O75157 | |
| TNTETSEMLLNGTGP | 486 | Q86VH5 | |
| SVADMTAPVVGSSGG | 266 | P58872 | |
| METNSSLPTNISGGT | 1 | P21462 | |
| TMQKQQGGSTGTSPT | 336 | Q96SF7 | |
| SMGGPNRNVTVTQTP | 901 | Q9Y6Q9 | |
| SGGSQPSMRQVGTSQ | 146 | Q86VE3 | |
| PSMRQVGTSQLGTSQ | 151 | Q86VE3 | |
| GSQPSMRQVGTSQSG | 391 | Q86VE3 | |
| TSQSGTSQIGMSQPG | 401 | Q86VE3 | |
| SQNGSLGSSVMAPVG | 41 | O43166 | |
| ASAASQTQMPTGQTG | 361 | Q9P2F8 | |
| PGTGRGLMSQTSLQE | 56 | Q9NVD3 | |
| TNMRAPSTTGGIGIN | 291 | Q15714 | |
| AAVSSVPNAAAGMTG | 376 | Q15714 | |
| VPNAAAGMTGGSVSS | 381 | Q15714 | |
| AGMTGGSVSSQQQQP | 386 | Q15714 | |
| TESVGSGEMGAPTVV | 481 | Q15714 | |
| TITLAPMQGVSLGQT | 481 | P08047 | |
| PMQGVSLGQTSSSNT | 486 | P08047 | |
| LNPSMVTNEGLGLTT | 851 | O00444 | |
| ETDSVGTPQSNGGMR | 271 | Q9H0H5 | |
| MSAIATNGVVPAGGS | 171 | Q9UP95 | |
| AGVVVSMSPAQLGTT | 321 | P53597 | |
| MSSQPAGNQTSPGAT | 1 | Q9BX79 | |
| TSFTLMPGGAVAQQV | 341 | P11831 | |
| STDTVTQGSQMNGSP | 551 | O95470 | |
| AGQTSRGVTMVSPST | 521 | Q7Z6J0 | |
| SAQESTPIMNGVTGP | 291 | Q9UQB8 | |
| LSVGSSPVGSEISMQ | 531 | P55197 | |
| NGVTVGALASGMQPV | 871 | P55197 | |
| QVAAAGVSSNPFMTG | 531 | P52594 | |
| NPRESTGNMVTGQTV | 581 | Q15021 | |
| SANQGVTGMPVSAFT | 541 | Q03692 | |
| NTGNGTQSSMGSPLT | 881 | O75122 | |
| GQGIGIPSRTNSMSS | 146 | Q9NZN8 | |
| MELQGGVPSSSQDSQ | 361 | Q6DJT9 | |
| QMRASNVSSDGGTEP | 91 | Q96N96 | |
| VSMCLQTGPTGGASN | 896 | Q15468 | |
| TAMTLTPGGNSVIVG | 231 | Q6RFH5 | |
| MLPSTSVNSLVQGNG | 1 | Q53HI1 | |
| EGSQPSTMDATAVAG | 371 | Q96CK0 | |
| SILTAGMQEQESSGP | 966 | O95625 | |
| GRMTAADSGQPGTQE | 116 | Q9UPR6 | |
| LSQMGVTTDGVPAQQ | 906 | Q96PV0 | |
| PLQQMVASGTGAVVT | 11 | Q9BZJ4 | |
| MPSSVTALGQARSSG | 1 | Q86WA9 | |
| PGTGGSQAELAQSTM | 121 | Q8IZW8 | |
| MGSSQPVVTRGTTDN | 236 | P08138 | |
| VGFSQSEMVTGEGSP | 1336 | Q9BXM0 | |
| PGSSSGLTATVAQAM | 681 | O15014 | |
| SPMSSGVQSGTPITN | 301 | Q96S82 | |
| SGSRVPMTFITNSNG | 841 | Q9Y2X9 | |
| GQVMTSDGTPLVGVN | 926 | Q6N022 | |
| TGTIQQQSTPGVFMG | 311 | Q8IYB5 | |
| PTGGIVDMASSTFQG | 3566 | Q709C8 | |
| EMLPGTSTGNNQSTI | 511 | Q2KHR2 | |
| PSQGSFGGGQTMTVT | 2006 | Q86WI1 | |
| TMTVTGTGFNPQNSI | 2016 | Q86WI1 | |
| QGMAGSLEGTTRPNV | 776 | Q9UGU0 | |
| SSPSIQDGGLMQASV | 636 | Q8NB14 | |
| LSSGIINGPFTMNSS | 21 | O95758 | |
| GMSDGNPELLSTSQT | 51 | Q96NM4 | |
| EIPNTTVSNFRGSMG | 311 | Q96JM2 | |
| EQGISPINMGLTSAS | 101 | O14948 | |
| APTRGAVMEQGTSSS | 1666 | Q9Y3S1 | |
| SNPNMVVSGSSDGLV | 181 | Q96FK6 | |
| EQQQPLGGSSSSMAV | 451 | P0DP72 | |
| SQTSMSGTLELPNIG | 296 | Q08ET2 | |
| PSTNGMFTLTTNGDL | 816 | P35125 | |
| QLTTGFQPSLASSGM | 311 | Q5VZL5 | |
| AVSLSSAGTPLVMGQ | 506 | Q8IZ20 | |
| GSQGSVMATLQLPAT | 731 | Q9ULM3 | |
| SMNTGNEGLPTSGSF | 951 | Q7Z3T8 | |
| GISSMPNITVGTQVC | 521 | O95071 | |
| PSSMDVNSRQLVGGS | 2781 | O14686 |